Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	1647871	1647871	T	C	exonic	CDK11A;CDK11B	.	synonymous SNV	CDK11A:NM_001313896:exon5:c.A372G:p.R124R,CDK11A:NM_001313982:exon5:c.A372G:p.R124R,CDK11A:NM_024011:exon5:c.A402G:p.R134R,CDK11A:NM_033529:exon5:c.A372G:p.R124R,CDK11B:NM_001291345:exon6:c.A372G:p.R124R,CDK11B:NM_001787:exon6:c.A402G:p.R134R,CDK11B:NM_033486:exon6:c.A402G:p.R134R,CDK11B:NM_033489:exon7:c.A300G:p.R100R	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	192	194	chr1	1647871	chr1:1647871	T	C	192	PASS	AN=2;DP=194	GT	0/1
chr1	1647893	1647893	-	TTTCTT	exonic	CDK11A;CDK11B	.	nonframeshift insertion	CDK11B:NM_001291345:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11A:NM_001313896:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11A:NM_001313982:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11B:NM_001787:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11A:NM_024011:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11B:NM_033486:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11A:NM_033529:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11B:NM_033489:exon6:c.277_278insAAGAAA:p.E92_R93insKE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	177	159	chr1	1647893	chr1:1647893	C	CTTTCTT	177	PASS	AN=2;DP=159	GT	0/1
chr1	1910301	1910301	C	T	intronic	CFAP74	.	.	.	.	.	.	.	0.12614	0.09843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	98	chr1	1910301	chr1:1910301	C	T	64	PASS	AN=2;DP=98	GT	0/1
chr1	10697270	10697270	C	A	UTR3	CASZ1	NM_001079843:c.*1729G>T	.	.	0.999938476	6.15E-05	4.86E-13	.	0.71675	0.27528	-2.416721768	1.055673508	1083.53567	6.31123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	235	chr1	10697270	chr1:10697270	C	A	102	PASS	AN=2;DP=235	GT	0/1
chr1	11036287	11036287	G	C	exonic	C1orf127	.	nonsynonymous SNV	C1orf127:NM_001170754:exon2:c.C53G:p.P18R	1.33E-05	0.955388217	0.044598438	.	0.1648	.	0.986521626	90.48124558	1056.79352	6.24152	0.035	0.437	D	.	.	.	.	.	.	.	.	.	1	0.216	N	.	.	.	1.44	0.327	T	-2.17	0.490	N	0.103	0.107	-1.024	0.225	T	0.050	0.215	T	0.007	0.179	T	4.095	0.550	23.7	0.997	0.828	0.065	0.124	N	c	-0.464	-0.526	1.000	0.747	0.487	0.094	0	2.82	0.319	1.516	0.352	0.978	0.596	0.014	0.188	0.056	0.168	8.923	0.346	.	.	.	0.5	.	95	chr1	11036287	chr1:11036287	G	C	.	PASS	AN=0;DP=95	GT	0/1
chr1	12943022	12943022	C	T	exonic	PRAMEF4	.	nonsynonymous SNV	PRAMEF4:NM_001009611:exon2:c.G194A:p.R65H	0.074609525	0.872447591	0.052942885	.	0.14569	.	3.532159363	99.48100967	1356.98129	6.91114	.	.	.	0.02	0.170	B	0.009	0.133	B	0.213	0.034	N	1	0.090	N	1.665	0.427	L	.	.	.	.	.	.	0.118	0.153	-0.921	0.455	T	0.025	0.108	T	0.001	0.010	T	0.283	0.121	5.523	0.602	0.062	0.005	0.023	N	c	-1.264	-1.399	0.000	0.012	0.487	0.133	0	0.542	0.163	0.297	0.187	0.529	0.282	0.096	0.225	0.032	0.149	4.846	0.128	.	.	.	0.5	96	189	chr1	12943022	chr1:12943022	C	T	96	PASS	AN=2;DP=189	GT	0/1
chr1	13052863	13052863	C	A	intronic	PRAMEF25;PRAMEF26	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	0.135	0.156	-0.974	0.364	T	0.100	0.371	T	.	.	.	-0.267	0.071	0.787	0.933	0.225	0.003	0.015	N	c	-0.773	-1.019	0.000	0.012	0.487	0.133	0	-1.09	0.093	-0.756	0.048	-0.339	0.072	0.000	0.063	0.002	0.062	3.460	0.070	.	.	.	0.5	110	393	chr1	13052863	chr1:13052863	C	A	110	PASS	AN=2;DP=393	GT	0/1
chr1	16302477	16302477	C	T	splicing	ZBTB17	NM_001287604:exon1:UTR5;NM_001242884:exon1:UTR5;NM_003443:exon1:UTR5;NM_001287603:exon1:UTR5;NM_001324137:exon1:UTR5;NM_001324138:exon1:UTR5	.	.	0.998165365	0.001834626	9.40E-09	.	0.9193	0.14584	-0.688817379	15.20405756	70.88543	1.75315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	132	chr1	16302477	chr1:16302477	C	T	67	PASS	AN=2;DP=132	GT	0/1
chr1	16363158	16363158	G	A	intergenic	CLCNKA;CLCNKB	dist=2613;dist=7073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	78	chr1	16363158	chr1:16363158	G	A	91	PASS	AN=2;DP=78	GT	0/1
chr1	16812113	16812113	G	A	ncRNA_exonic	CROCCP3	.	.	.	.	.	.	.	0.06928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	162	chr1	16812113	chr1:16812113	G	A	140	PASS	AN=2;DP=162	GT	0/1
chr1	17034456	17034463	GCGCGCGT	-	ncRNA_exonic	ESPNP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	123	chr1	17034455	chr1:17034455	CGCGCGCGT	C	150	PASS	AN=2;DP=123	GT	0/1
chr1	17086941	17086941	C	T	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon4:c.G383A:p.R128H	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	480	chr1	17086941	chr1:17086941	C	T	125	PASS	AN=2;DP=480	GT	0/1
chr1	19246151	19246151	G	-	intronic	IFFO2	.	.	.	0.382583916	0.573000165	0.044415918	.	.	.	.	.	254.06335	3.42814	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	172	chr1	19246150	chr1:19246150	AG	A	92	PASS	AN=2;DP=172	GT	0/1
chr1	22922560	22922560	G	A	intronic	EPHA8	.	.	.	1.14E-08	0.983030391	0.016969598	.	0.32535	0.12252	0.130330208	63.21066289	1372.14313	6.94837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	61	chr1	22922560	chr1:22922560	G	A	129	PASS	AN=2;DP=61	GT	0/1
chr1	23695969	23695969	G	C	ncRNA_exonic	ZNF436-AS1	.	.	.	.	.	.	.	0.12418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	199	chr1	23695969	chr1:23695969	G	C	100	PASS	AN=2;DP=199	GT	0/1
chr1	25634235	25634235	G	T	exonic	RHD	.	nonsynonymous SNV	RHD:NM_001282871:exon8:c.G1171T:p.V391F,RHD:NM_001282872:exon8:c.G1171T:p.V391F	0.0060601	0.97290792	0.021031981	.	0.40369	.	3.311471185	99.41613588	1433.80387	7.06993	0.253	0.169	T	0.985	0.592	D	0.488	0.455	P	.	.	.	1	0.090	N	.	.	.	1.84	0.247	T	0.62	0.079	N	0.139	0.162	-1.046	0.156	T	0.057	0.238	T	0.001	0.020	T	-0.167	0.079	1.280	0.988	0.453	0.010	0.038	N	c	-0.564	-0.811	0.000	0.067	0.554	0.283	0	0.996	0.189	-0.266	0.086	0.321	0.271	0.000	0.063	0.041	0.157	5.378	0.154	Ammonium transporter AmtB-like domain|Ammonium/urea transporter	.	.	0.5	110	212	chr1	25634235	chr1:25634235	G	T	110	PASS	AN=2;DP=212	GT	0/1
chr1	70877188	70877188	G	T	exonic	CTH	.	nonsynonymous SNV	CTH:NM_001190463:exon1:c.G90T:p.E30D,CTH:NM_001902:exon1:c.G90T:p.E30D,CTH:NM_153742:exon1:c.G90T:p.E30D	4.09E-05	0.955744395	0.044214725	DISEASE: Cystathioninuria (CSTNU) [MIM:219500]: Autosomal recessive phenotype characterized by abnormal accumulation of plasma cystathionine, leading to increased urinary excretion. {ECO:0000269|PubMed:12574942}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24604	.	0.194852702	67.03231894	1258.99689	6.6911	0.902	0.024	T	0.041	0.200	B	0.074	0.267	B	0.000	0.843	D	1	0.810	D	-0.66	0.021	N	-0.44	0.808	T	-1.54	0.389	N	0.299	0.369	-0.944	0.420	T	0.075	0.301	T	0.024	0.475	T	0.842	0.174	9.720	0.853	0.153	0.909	0.522	D	c	-0.780	-0.540	1.000	0.747	0.442	0.072	0	3.39	0.378	2.628	0.459	0.108	0.203	1.000	0.715	0.209	0.219	5.791	0.175	Pyridoxal phosphate-dependent transferase, major region, subdomain 1	.	.	0.5	81	194	chr1	70877188	chr1:70877188	G	T	81	PASS	AN=2;DP=194	GT	0/1
chr1	86488534	86488534	A	T	exonic	COL24A1	.	synonymous SNV	COL24A1:NM_001349955:exon16:c.T30A:p.P10P,COL24A1:NM_152890:exon16:c.T2130A:p.P710P	1.06E-25	0.975699922	0.024300078	.	0.15994	0.11186	0.79541165	87.41448455	9574.81397	21.18138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	186	chr1	86488534	chr1:86488534	A	T	85	PASS	AN=2;DP=186	GT	0/1
chr1	89655964	89655964	G	C	exonic	GBP4	.	nonsynonymous SNV	GBP4:NM_052941:exon7:c.C954G:p.I318M	1.42E-09	0.347776877	0.652223122	.	0.06048	.	1.758248793	96.72682236	364.12153	4.03932	0.0	0.912	D	0.996	0.670	D	0.969	0.703	D	0.000	0.843	D	1.000	0.090	N	4.12	0.975	H	3.47	0.052	T	-2.89	0.606	D	0.632	0.650	-1.019	0.241	T	0.043	0.183	T	0.003	0.075	T	3.396	0.466	23.0	0.994	0.632	0.829	0.417	D	c	0.407	0.180	0.932	0.270	0.707	0.730	0	3.41	0.380	3.533	0.531	0.966	0.591	1.000	0.715	0.003	0.074	5.015	0.136	Guanylate-binding protein, C-terminal	.	.	0.5	77	74	chr1	89655964	chr1:89655964	G	C	77	PASS	AN=2;DP=74	GT	0/1
chr1	104203042	104203042	C	T	exonic	AMY1A;AMY1B;AMY1C	.	synonymous SNV	AMY1B:NM_001008218:exon7:c.C939T:p.N313N,AMY1C:NM_001008219:exon7:c.C939T:p.N313N,AMY1A:NM_001008221:exon7:c.C939T:p.N313N,AMY1C:NM_001346780:exon7:c.C939T:p.N313N,AMY1A:NM_004038:exon7:c.C939T:p.N313N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	400	chr1	104203042	chr1:104203042	C	T	127	PASS	AN=2;DP=400	GT	0/1
chr1	110257506	110257506	G	C	intronic	GSTM5	.	.	.	0.000214167	0.736990281	0.262795552	.	0.04393	.	0.905808022	89.4373673	506.91274	4.62021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	82	chr1	110257506	chr1:110257506	G	C	.	PASS	AN=0;DP=82	GT	0/1
chr1	111026677	111026677	C	A	ncRNA_intronic	CYMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	283	chr1	111026677	chr1:111026677	C	A	108	PASS	AN=2;DP=283	GT	0/1
chr1	112998640	112998640	A	C	exonic	CTTNBP2NL	.	nonsynonymous SNV	CTTNBP2NL:NM_018704:exon6:c.A526C:p.K176Q	0.141381252	0.854550662	0.004068086	.	0.23525	0.10978	-0.067881249	48.69072895	134.44599	2.52148	0.103	0.301	T	0.999	0.764	D	0.985	0.749	D	0.000	0.843	D	1	0.810	D	1.925	0.515	L	0.52	0.553	T	-3.33	0.662	D	0.641	0.657	-0.644	0.630	T	0.237	0.605	T	0.015	0.350	T	4.243	0.568	23.9	0.994	0.624	0.987	0.856	D	c	0.766	0.781	1.000	0.747	0.707	0.730	0	6.07	0.987	7.130	0.767	1.199	0.960	1.000	0.715	1.000	0.888	16.290	0.825	Cortactin-binding protein-2, N-terminal	.	.	0.5	128	93	chr1	112998640	chr1:112998640	A	C	128	PASS	AN=2;DP=93	GT	0/1
chr1	142825055	142825055	C	A	intergenic	ANKRD20A12P;LOC102723769	dist=111450;dist=309548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	165	1016	chr1	142825055	chr1:142825055	C	A	165	PASS	AN=2;DP=1016	GT	0/1
chr1	143378854	143378854	G	A	intergenic	LOC102723769;MIR6077	dist=176615;dist=294067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	174	463	chr1	143378854	chr1:143378854	G	A	174	PASS	AN=2;DP=463	GT	0/1
chr1	143391793	143391793	G	T	intergenic	LOC102723769;MIR6077	dist=189554;dist=281128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	1585	chr1	143391793	chr1:143391793	G	T	124	PASS	AN=2;DP=1585	GT	0/1
chr1	143392481	143392481	C	A	intergenic	LOC102723769;MIR6077	dist=190242;dist=280440	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	672	chr1	143392481	chr1:143392481	C	A	155	PASS	AN=2;DP=672	GT	0/1
chr1	143400876	143400876	C	A	intergenic	LOC102723769;MIR6077	dist=198637;dist=272045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	269	chr1	143400876	chr1:143400876	C	A	114	PASS	AN=2;DP=269	GT	0/1
chr1	144813824	144813824	G	C	exonic	NBPF8;NBPF9	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	411	chr1	144813824	chr1:144813824	G	C	130	PASS	AN=2;DP=411	GT	0/1
chr1	144856817	144856817	T	C	exonic	PDE4DIP	.	nonsynonymous SNV	PDE4DIP:NM_001350520:exon36:c.A7154G:p.E2385G,PDE4DIP:NM_001198834:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_014644:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_001350522:exon41:c.A6509G:p.E2170G,PDE4DIP:NM_001198832:exon42:c.A6350G:p.E2117G,PDE4DIP:NM_001350521:exon42:c.A6962G:p.E2321G,PDE4DIP:NM_001350523:exon42:c.A6347G:p.E2116G	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	c	0.152	0.039	1.000	0.517	0.598	0.340	0	3.39	0.378	3.846	0.554	0.183	0.247	1.000	0.715	0.636	0.296	8.617	0.328	.	.	.	0.5	130	261	chr1	144856817	chr1:144856817	T	C	130	PASS	AN=2;DP=261	GT	0/1
chr1	144879592	144879592	A	T	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	175	chr1	144879592	chr1:144879592	A	T	119	PASS	AN=2;DP=175	GT	0/1
chr1	144994902	144994902	G	A	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	148	chr1	144994902	chr1:144994902	G	A	112	PASS	AN=2;DP=148	GT	0/1
chr1	145290398	145290398	G	A	ncRNA_intronic	NBPF25P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	270	chr1	145290398	chr1:145290398	G	A	131	PASS	AN=2;DP=270	GT	0/1
chr1	149784994	149784994	C	T	exonic	HIST2H3D	.	synonymous SNV	HIST2H3D:NM_001123375:exon1:c.G243A:p.T81T	0.49893728	0.427580174	0.073482546	.	.	.	0.035072054	56.2514744	6.52563	0.24176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	295	chr1	149784994	chr1:149784994	C	T	.	PASS	AN=0;DP=295	GT	0/1
chr1	149859345	149859345	G	A	exonic	HIST2H2AB	.	nonsynonymous SNV	HIST2H2AB:NM_175065:exon1:c.C122T:p.A41V	0.216215034	0.647861978	0.135922988	.	0.94267	0.1705	-0.119252484	44.53880632	2.43929	0.08861	0.0	0.912	D	1.0	0.899	D	0.981	0.736	D	0.000	0.629	D	1	0.810	D	4.095	0.974	H	-0.53	0.708	T	-3.31	0.659	D	0.515	0.558	0.359	0.885	D	0.583	0.850	D	0.049	0.636	D	3.844	0.519	23.4	0.994	0.649	0.910	0.524	D	c	0.944	0.841	1.0	0.983	0.025	0.001	3	5.27	0.737	6.768	0.746	1.036	0.656	1.000	0.715	0.985	0.512	12.482	0.550	Histone H2A/H2B/H3|Histone-fold	.	.	0.5	122	508	chr1	149859345	chr1:149859345	G	A	122	PASS	AN=2;DP=508	GT	0/1
chr1	152128618	152128689	GTAGTGGGAACTCTGGCCTTGTCTGTCTGTCTGACCATAATGATAACTCTGGTCTTGTCTGTCCGTCTGACC	-	exonic	RPTN	.	nonframeshift deletion	RPTN:NM_001122965:exon3:c.886_957del:p.G296_Y319del	3.18E-18	0.004475026	0.995524974	.	0.09608	.	1.243805243	93.41825902	382.87927	4.1263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	393	chr1	152128617	chr1:152128617	TGTAGTGGGAACTCTGGCCTTGTCTGTCTGTCTGACCATAATGATAACTCTGGTCTTGTCTGTCCGTCTGACC	T	76	PASS	AN=2;DP=393	GT	0/1
chr1	156552913	156552913	G	T	exonic	TTC24	.	nonsynonymous SNV	TTC24:NM_001105669:exon3:c.G990T:p.K330N	6.58E-05	0.723355769	0.276578427	.	0.129	.	0.841481379	88.35810333	4269.00298	12.99213	0.172	0.226	T	0.837	0.444	P	0.233	0.367	B	0.918	0.085	N	1.000	0.090	N	0.405	0.124	N	-1.06	0.768	T	-0.88	0.238	N	0.142	0.166	-0.968	0.377	T	0.018	0.077	T	0.017	0.383	T	1.960	0.296	15.96	0.990	0.494	0.586	0.304	D	c	-0.398	-0.425	1.000	0.473	0.497	0.185	0	-0.371	0.118	0.577	0.233	-0.774	0.033	1.000	0.715	0.143	0.203	4.581	0.116	Tetratricopeptide repeat-containing domain|Tetratricopeptide-like helical domain	.	.	0.5	75	160	chr1	156552913	chr1:156552913	G	T	75	PASS	AN=2;DP=160	GT	0/1
chr1	168201088	168201088	G	A	exonic	SFT2D2	.	stopgain	SFT2D2:NM_199344:exon3:c.G167A:p.W56X	0.003949651	0.855531759	0.140518591	.	0.10989	.	-0.229483771	36.86010852	10.43983	0.37986	.	.	.	.	.	.	.	.	.	0.003	0.350	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.245	0.973	37	0.991	0.519	0.879	0.473	D	c	0.950	0.769	1.000	0.747	0.706	0.609	0	5.57	0.840	4.828	0.622	0.953	0.551	1.000	0.715	0.994	0.587	16.471	0.839	.	.	.	0.5	110	246	chr1	168201088	chr1:168201088	G	A	110	PASS	AN=2;DP=246	GT	0/1
chr1	186089252	186089252	G	T	exonic	HMCN1	.	nonsynonymous SNV	HMCN1:NM_031935:exon80:c.G12204T:p.L4068F	2.19E-18	1	6.42E-24	.	0.11657	0.21661	-3.689691478	0.247699929	8270.20936	19.62945	0.303	0.143	T	1.0	0.899	D	0.998	0.875	D	0.000	0.537	D	1.000	0.537	D	0.36	0.120	N	-0.23	0.667	T	-2.27	0.506	N	0.37	0.431	-0.669	0.619	T	0.238	0.606	T	0.032	0.542	D	4.125	0.553	23.8	0.998	0.882	0.937	0.586	D	c	0.287	0.289	0.001	0.082	0.638	0.428	0	2.97	0.333	2.643	0.460	0.089	0.194	1.000	0.715	0.993	0.574	5.862	0.179	Immunoglobulin I-set|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	105	149	chr1	186089252	chr1:186089252	G	T	105	PASS	AN=2;DP=149	GT	0/1
chr1	219347141	219347141	G	T	upstream	LYPLAL1;LYPLAL1-AS1	dist=32	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	85	chr1	219347141	chr1:219347141	G	T	82	PASS	AN=2;DP=85	GT	0/1
chr1	228335908	228335908	G	T	intronic	GUK1	.	.	.	0.00010002	0.573762218	0.426137762	.	0.61935	0.39826	-0.957024976	9.088228356	85.40721	1.97028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	109	chr1	228335908	chr1:228335908	G	T	.	PASS	AN=0;DP=109	GT	0/1
chr1	237167584	237167584	T	C	exonic	MT1HL1	.	nonsynonymous SNV	MT1HL1:NM_001276687:exon1:c.A89G:p.K30R	0.020062126	0.511088562	0.468849312	.	.	.	.	.	93.79969	2.08288	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.192	0.235	.	.	.	.	.	.	0.001	0.004	T	1.077	0.197	11.09	0.740	0.102	0.211	0.211	N	n	0.595	-0.059	0.022	0.134	0.263	0.038	0	0.991	0.188	0.671	0.247	0.368	0.274	0.999	0.424	0.428	0.259	4.242	0.100	Metallothionein domain|Metallothionein domain, vertebrate|TNFR/NGFR cysteine-rich region	.	.	0.5	102	109	chr1	237167584	chr1:237167584	T	C	102	PASS	AN=2;DP=109	GT	0/1
chr1	240775299	240775299	C	A	ncRNA_intronic	MIR1273E	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	75	chr1	240775299	chr1:240775299	C	A	.	PASS	AN=0;DP=75	GT	0/1
chr2	1983507	1983507	T	C	exonic	MYT1L	.	nonsynonymous SNV	MYT1L:NM_001303052:exon6:c.A43G:p.K15E,MYT1L:NM_001329845:exon6:c.A43G:p.K15E,MYT1L:NM_001329846:exon6:c.A43G:p.K15E,MYT1L:NM_001329847:exon6:c.A43G:p.K15E,MYT1L:NM_001329848:exon6:c.A43G:p.K15E,MYT1L:NM_001329849:exon6:c.A43G:p.K15E,MYT1L:NM_001329851:exon6:c.A43G:p.K15E,MYT1L:NM_001329852:exon6:c.A43G:p.K15E,MYT1L:NM_015025:exon6:c.A43G:p.K15E,MYT1L:NM_001329844:exon7:c.A43G:p.K15E	0.999963989	3.60E-05	6.51E-13	.	0.30683	0.11638	-1.506435464	3.544468035	525.36937	4.67655	0.003	0.682	D	0.956	0.559	P	0.899	0.676	P	0.000	0.843	D	1.000	0.537	D	2.625	0.771	M	0.02	0.623	T	-2.59	0.558	D	0.792	0.782	-0.299	0.750	T	0.360	0.722	T	0.029	0.519	D	4.511	0.604	24.3	0.996	0.723	0.965	0.695	D	c	0.634	0.634	1.000	0.517	0.487	0.133	0	5.1	0.688	6.281	0.725	0.913	0.425	1.000	0.715	1.000	0.888	15.192	0.726	.	.	.	0.5	.	101	chr2	1983507	chr2:1983507	T	C	.	PASS	AN=0;DP=101	GT	0/1
chr2	3488595	3488595	G	C	intergenic	TRAPPC12;ADI1	dist=5253;dist=13095	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	175	chr2	3488595	chr2:3488595	G	C	73	PASS	AN=2;DP=175	GT	0/1
chr2	12164729	12164729	A	T	ncRNA_intronic	MIR3681HG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	120	chr2	12164729	chr2:12164729	A	T	.	PASS	AN=0;DP=120	GT	0/1
chr2	25497908	25497908	G	A	exonic	DNMT3A	.	nonsynonymous SNV	DNMT3A:NM_022552:exon6:c.C541T:p.R181C,DNMT3A:NM_175629:exon6:c.C541T:p.R181C	7.73E-45	8.72E-11	1	DISEASE: Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]: An overgrowth syndrome characterized by a distinctive facial appearance, tall stature and intellectual disability. Facial gestalt is characterized by a round face, heavy horizontal eyebrows and narrow palpebral fissures. Less common features include atrial septal defects, seizures, umbilical hernia, and scoliosis. {ECO:0000269|PubMed:24614070}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.88689	0.41514	-1.131590109	6.481481481	41.83604	1.21826	0.0	0.912	D	1.0	0.899	D	0.973	0.713	D	0.000	0.629	D	1	0.810	D	0.55	0.145	N	-4.25	0.971	D	-3.97	0.736	D	0.825	0.813	1.034	0.978	D	0.895	0.965	D	0.572	0.961	D	6.239	0.861	28.8	0.999	0.967	0.941	0.599	D	c	0.685	0.719	1.000	0.747	0.722	0.854	0	5.24	0.728	9.119	0.936	0.948	0.535	1.000	0.715	1.000	0.888	16.329	0.828	.	.	.	0.5	.	117	chr2	25497908	chr2:25497908	G	A	.	PASS	AN=0;DP=117	GT	0/1
chr2	74668346	74668346	T	A	intronic	RTKN	.	.	.	0.000149538	0.992324331	0.007526131	.	0.1644	0.10277	-0.841329384	11.36470866	111.05692	2.29721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	279	chr2	74668346	chr2:74668346	T	A	127	PASS	AN=2;DP=279	GT	0/1
chr2	90077766	90077766	C	G	intergenic	MIR4436A;LOC654342	dist=965798;dist=1746943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	371	chr2	90077766	chr2:90077766	C	G	130	PASS	AN=2;DP=371	GT	0/1
chr2	90211702	90211702	C	A	intergenic	MIR4436A;LOC654342	dist=1099734;dist=1613007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	362	chr2	90211702	chr2:90211702	C	A	118	PASS	AN=2;DP=362	GT	0/1
chr2	91800851	91800851	T	C	intergenic	NONE;LOC654342	dist=NONE;dist=23858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	569	chr2	91800851	chr2:91800851	T	C	103	PASS	AN=2;DP=569	GT	0/1
chr2	96617102	96617102	C	T	exonic	ANKRD36C	.	nonsynonymous SNV	ANKRD36C:NM_001310154:exon15:c.G1258A:p.E420K	.	.	.	.	.	.	.	.	2676.37542	9.72635	0.356	0.120	T	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	2.18	0.189	T	-0.23	0.107	N	0.084	0.246	-0.990	0.327	T	0.025	0.109	T	.	.	.	-0.620	0.049	0.112	0.589	0.059	0.000	0.002	N	c	-1.003	-1.160	0.000	0.038	0.581	0.330	0	0.406	0.155	0.404	0.206	-0.320	0.077	0.064	0.217	0.001	0.043	3.230	0.063	.	.	.	0.5	91	186	chr2	96617102	chr2:96617102	C	T	91	PASS	AN=2;DP=186	GT	0/1
chr2	96697823	96697823	G	A	exonic	GPAT2	.	synonymous SNV	GPAT2:NM_001321525:exon3:c.C135T:p.P45P,GPAT2:NM_001321526:exon3:c.C135T:p.P45P,GPAT2:NM_001321527:exon3:c.C135T:p.P45P,GPAT2:NM_001321528:exon3:c.C135T:p.P45P,GPAT2:NM_001321529:exon3:c.C135T:p.P45P,GPAT2:NM_001321530:exon3:c.C135T:p.P45P,GPAT2:NM_207328:exon3:c.C135T:p.P45P,GPAT2:NM_001321531:exon4:c.C135T:p.P45P	0.0016123	0.992339401	0.006048299	.	.	.	.	.	151.08322	2.68731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	161	395	chr2	96697823	chr2:96697823	G	A	161	PASS	AN=2;DP=395	GT	0/1
chr2	109356988	109356988	G	C	exonic	RANBP2	.	nonsynonymous SNV	RANBP2:NM_006267:exon7:c.G826C:p.D276H	0.999999999	1.49E-09	4.67E-27	DISEASE: Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]: A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem. {ECO:0000269|PubMed:19118815}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by themselves are insufficient to make the phenotype fully penetrant; additional genetic and environmental factors are required (PubMed:19118815). {ECO:0000269|PubMed:19118815}.; 	0.93164	0.52169	-1.538551197	3.33215381	1024.97017	6.15454	0.004	0.654	D	0.996	0.670	D	0.831	0.578	P	.	.	.	0.951	0.377	D	2.645	0.776	M	1.53	0.304	T	-3.05	0.629	D	0.485	0.623	-0.912	0.466	T	0.126	0.432	T	0.016	0.378	T	3.831	0.517	23.4	0.994	0.618	0.996	0.976	D	c	0.721	0.716	0.972	0.293	0.707	0.730	0	4.79	0.608	9.401	0.966	1.038	0.658	1.000	0.715	1.000	0.888	11.696	0.506	Tetratricopeptide-like helical domain	.	.	0.5	143	373	chr2	109356988	chr2:109356988	G	C	143	PASS	AN=2;DP=373	GT	0/1
chr2	109960809	109960809	G	T	intronic	SH3RF3	.	.	.	0.981100872	0.018885189	1.39E-05	.	.	.	.	.	1390.76659	6.97706	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.231	0.074	0.945	0.713	0.093	0.095	0.150	N	n	-0.099	-0.182	1.000	0.473	0.054	0.004	0	0.474	0.159	1.163	0.312	0.635	0.291	0.004	0.165	0.015	0.124	5.12	0.141	.	.	.	0.5	97	225	chr2	109960809	chr2:109960809	G	T	97	PASS	AN=2;DP=225	GT	0/1
chr2	122006480	122006480	C	T	intronic	TFCP2L1	.	.	.	0.999192587	0.000807412	1.27E-09	.	0.12962	0.10362	-0.400392389	26.85185185	222.44013	3.22468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	195	chr2	122006480	chr2:122006480	C	T	65	PASS	AN=2;DP=195	GT	0/1
chr2	132014501	132014501	G	T	intronic	POTEE	.	.	.	.	.	.	.	.	.	.	.	513.98926	4.63955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	173	chr2	132014501	chr2:132014501	G	T	.	PASS	AN=0;DP=173	GT	0/1
chr2	132366964	132366964	T	C	ncRNA_exonic	POTEKP	.	.	.	.	.	.	.	.	0.43916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	141	305	chr2	132366964	chr2:132366964	T	C	141	PASS	AN=2;DP=305	GT	0/1
chr2	175199798	175199798	C	T	upstream	SP9	dist=23	.	.	0.498147938	0.428018312	0.07383375	.	.	.	.	.	26.65009	0.86255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	280	chr2	175199798	chr2:175199798	C	T	114	PASS	AN=2;DP=280	GT	0/1
chr2	179557235	179557235	G	T	exonic	TTN	.	nonsynonymous SNV	TTN:NM_133378:exon117:c.C27935A:p.P9312Q,TTN:NM_001256850:exon118:c.C30716A:p.P10239Q,TTN:NM_001267550:exon120:c.C31667A:p.P10556Q	1.21E-32	1	5.79E-127	DISEASE: Hereditary myopathy with early respiratory failure (HMERF) [MIM:603689]: Autosomal dominant, adult-onset myopathy with early respiratory muscle involvement. {ECO:0000269|PubMed:15802564}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 9 (CMH9) [MIM:613765]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:10462489}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1G (CMD1G) [MIM:604145]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11788824, ECO:0000269|PubMed:11846417, ECO:0000269|PubMed:16465475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tardive tibial muscular dystrophy (TMD) [MIM:600334]: Autosomal dominant, late-onset distal myopathy. Muscle weakness and atrophy are usually confined to the anterior compartment of the lower leg, in particular the tibialis anterior muscle. Clinical symptoms usually occur at age 35-45 years or much later. {ECO:0000269|PubMed:12145747, ECO:0000269|PubMed:12891679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Limb-girdle muscular dystrophy 2J (LGMD2J) [MIM:608807]: An autosomal recessive degenerative myopathy characterized by progressive weakness of the pelvic and shoulder girdle muscles. Severe disability is observed within 20 years of onset. {ECO:0000269|PubMed:12145747}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Early-onset myopathy with fatal cardiomyopathy (EOMFC) [MIM:611705]: Early-onset myopathies are inherited muscle disorders that manifest typically from birth or infancy with hypotonia, muscle weakness, and delayed motor development. EOMFC is a titinopathy that, in contrast with the previously described examples, involves both heart and skeletal muscle, has a congenital onset, and is purely recessive. This phenotype is due to homozygous out-of-frame TTN deletions, which lead to a total absence of titin's C-terminal end from striated muscles and to secondary CAPN3 depletion. {ECO:0000269|PubMed:17444505}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40699	0.38418	2.169883458	98.04199104	74772.86558	42.91324	0.009	0.721	D	0.948	0.604	P	0.694	0.610	P	.	.	.	1	0.810	D	.	.	.	-0.27	0.674	T	-3.33	0.832	D	0.265	0.335	0.050	0.833	D	0.474	0.798	T	0.050	0.643	D	1.876	0.286	15.44	0.974	0.334	0.952	0.636	D	c	0.550	0.477	0.609	0.218	0.487	0.133	0	4.54	0.551	4.643	0.608	0.948	0.535	1.000	0.715	0.672	0.303	13.348	0.599	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	76	151	chr2	179557235	chr2:179557235	G	T	76	PASS	AN=2;DP=151	GT	0/1
chr2	210737613	210737613	G	T	exonic	UNC80	.	synonymous SNV	UNC80:NM_032504:exon23:c.G3765T:p.R1255R,UNC80:NM_182587:exon23:c.G3750T:p.R1250R	0.139839111	0.85601101	0.00414988	.	0.61288	.	0.992010122	90.49893843	987.20517	6.05851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	chr2	210737613	chr2:210737613	G	T	.	PASS	AN=0;DP=85	GT	0/1
chr2	216241244	216241244	T	A	exonic	FN1	.	nonsynonymous SNV	FN1:NM_001306131:exon34:c.A5321T:p.D1774V,FN1:NM_001306132:exon34:c.A5321T:p.D1774V,FN1:NM_212474:exon34:c.A5321T:p.D1774V,FN1:NM_212476:exon34:c.A5321T:p.D1774V,FN1:NM_001306130:exon35:c.A5594T:p.D1865V,FN1:NM_002026:exon35:c.A5591T:p.D1864V,FN1:NM_212478:exon35:c.A5591T:p.D1864V,FN1:NM_001306129:exon36:c.A5864T:p.D1955V,FN1:NM_212482:exon36:c.A5864T:p.D1955V	0.064441538	0.935558462	2.07E-16	DISEASE: Glomerulopathy with fibronectin deposits 2 (GFND2) [MIM:601894]: Genetically heterogeneous autosomal dominant disorder characterized clinically by proteinuria, microscopic hematuria, and hypertension that leads to end-stage renal failure in the second to fifth decade of life. {ECO:0000269|PubMed:18268355}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.92203	0.99216	-2.323170444	1.18542109	825.54252	5.63214	0.001	0.912	D	0.996	0.689	D	0.998	0.875	D	0.001	0.432	D	1	0.810	D	2.43	0.707	M	0.4	0.573	T	-5.66	0.912	D	0.731	0.739	-0.140	0.792	T	0.395	0.748	T	0.094	0.762	D	6.174	0.852	28.6	0.994	0.640	0.969	0.714	D	c	0.654	0.648	1.000	0.747	0.732	0.924	0	5.91	0.952	6.255	0.722	1.061	0.807	1.000	0.715	0.837	0.349	16.348	0.829	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	115	216	chr2	216241244	chr2:216241244	T	A	115	PASS	AN=2;DP=216	GT	0/1
chr2	233246153	233246153	C	T	intronic	ALPP	.	.	.	1.69E-06	0.862682097	0.137316218	.	0.11261	0.13673	1.35769336	94.43854683	1957.1571	8.14348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	98	chr2	233246153	chr2:233246153	C	T	81	PASS	AN=2;DP=98	GT	0/1
chr2	233791834	233791834	C	A	exonic	NGEF	.	nonsynonymous SNV	NGEF:NM_001114090:exon2:c.G170T:p.S57I,NGEF:NM_019850:exon4:c.G446T:p.S149I	0.949825525	0.050173168	1.31E-06	.	0.30052	0.12355	-0.33061537	30.82094834	85.46834	1.97133	0.007	0.599	D	0.838	0.568	P	0.205	0.503	B	0.001	0.416	D	0.907	0.292	N	0.975	0.246	L	-0.48	0.719	T	-2.58	0.556	D	0.333	0.419	-0.608	0.645	T	0.252	0.622	T	0.027	0.500	D	4.233	0.567	23.9	0.993	0.571	0.895	0.497	D	c	0.292	0.360	1.000	0.747	0.598	0.340	0	4.84	0.620	1.994	0.401	0.935	0.490	1.000	0.715	1.000	0.888	10.72	0.450	.	.	.	0.5	74	127	chr2	233791834	chr2:233791834	C	A	74	PASS	AN=2;DP=127	GT	0/1
chr3	4534940	4534940	G	-	upstream	ITPR1;ITPR1-AS1	dist=92	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	136	chr3	4534939	chr3:4534939	CG	C	110	PASS	AN=2;DP=136	GT	0/1
chr3	43408393	43408393	G	A	UTR3	ANO10	NM_001204834:c.*5C>T;NM_001346465:c.*5C>T;NM_001204831:c.*107C>T;NM_001204833:c.*5C>T;NM_001346468:c.*5C>T;NM_001346464:c.*5C>T;NM_001204832:c.*5C>T;NM_018075:c.*5C>T;NM_001346469:c.*5C>T;NM_001346463:c.*5C>T;NM_001346466:c.*5C>T;NM_001346467:c.*5C>T	.	.	1.92E-06	0.880526516	0.119471561	.	0.13961	0.09565	0.957177419	90.14508139	912.19278	5.8726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	163	chr3	43408393	chr3:43408393	G	A	93	PASS	AN=2;DP=163	GT	0/1
chr3	74334562	74334562	T	G	exonic	CNTN3	.	synonymous SNV	CNTN3:NM_020872:exon19:c.A2598C:p.L866L	0.014141786	0.985856032	2.18E-06	.	0.27019	0.43019	0.316000233	72.80018872	1496.00916	7.19616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	151	chr3	74334562	chr3:74334562	T	G	107	PASS	AN=2;DP=151	GT	0/1
chr3	75478216	75478216	C	A	ncRNA_intronic	FAM86DP	.	.	.	.	.	.	.	0.06283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	276	chr3	75478216	chr3:75478216	C	A	140	PASS	AN=2;DP=276	GT	0/1
chr3	97439081	97439081	A	C	intronic	EPHA6	.	.	.	0.954513147	0.045486811	4.19E-08	.	0.34698	.	-0.771553417	13.15168672	252.47147	3.41934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	107	chr3	97439081	chr3:97439081	A	C	95	PASS	AN=2;DP=107	GT	0/1
chr3	116088777	116088777	A	G	ncRNA_exonic	LSAMP-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	88	chr3	116088777	chr3:116088777	A	G	101	PASS	AN=2;DP=88	GT	0/1
chr3	145879271	145879271	G	T	UTR5	PLOD2	NM_000935:c.-495C>A;NM_182943:c.-495C>A	.	.	0.00117484	0.998744975	8.02E-05	DISEASE: Note=PLOD2 mutations give rise to a broad variety of phenotypes with variable degrees of severity of bone fragility and joint contractures. Disease-associated mutations have been found in patients with autosomal recessive osteogenesis imperfecta (AR- OI) (PubMed:22689593). {ECO:0000269|PubMed:22689593}.; 	0.65048	0.12778	0.112125503	62.09601321	137.52121	2.55175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	277	chr3	145879271	chr3:145879271	G	T	125	PASS	AN=2;DP=277	GT	0/1
chr3	164786506	164786506	G	T	intronic	SI	.	.	.	7.97E-26	0.86464771	0.13535229	DISEASE: Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]: Autosomal recessive intestinal disorder that is clinically characterized by fermentative diarrhea, abdominal pain, and cramps upon ingestion of sugar. The symptoms are the consequence of absent or drastically reduced enzymatic activities of sucrase and isomaltase. The prevalence of CSID is 0.02 % in individuals of European descent and appears to be much higher in Greenland, Alaskan, and Canadian native people. CSID arises due to post-translational perturbations in the intracellular transport, polarized sorting, aberrant processing, and defective function of SI. {ECO:0000269|PubMed:10903344, ECO:0000269|PubMed:11340066, ECO:0000269|PubMed:14724820, ECO:0000269|PubMed:16329100, ECO:0000269|PubMed:8609217}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07211	0.17154	0.666787636	84.61901392	2753.13216	9.89427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	204	chr3	164786506	chr3:164786506	G	T	116	PASS	AN=2;DP=204	GT	0/1
chr3	184062437	184062437	G	T	exonic	FAM131A	.	synonymous SNV	FAM131A:NM_001171093:exon6:c.G525T:p.L175L,FAM131A:NM_144635:exon6:c.G780T:p.L260L	0.031328424	0.925656059	0.043015517	.	0.38029	0.09699	-0.205617011	38.57631517	64.91238	1.65518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	140	chr3	184062437	chr3:184062437	G	T	.	PASS	AN=0;DP=140	GT	0/1
chr3	185906191	185906191	C	T	intronic	DGKG	.	.	.	5.44E-06	0.99850148	0.001493082	.	0.45176	0.18992	-1.524862616	3.42061807	110.98235	2.29646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	chr3	185906191	chr3:185906191	C	T	.	PASS	AN=0;DP=79	GT	0/1
chr3	195391050	195391050	A	G	ncRNA_exonic	SDHAP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	445	chr3	195391050	chr3:195391050	A	G	122	PASS	AN=2;DP=445	GT	0/1
chr3	195400841	195400841	C	A	ncRNA_exonic	SDHAP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	317	chr3	195400841	chr3:195400841	C	A	144	PASS	AN=2;DP=317	GT	0/1
chr3	195410627	195410627	A	G	ncRNA_exonic	SDHAP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	382	chr3	195410627	chr3:195410627	A	G	130	PASS	AN=2;DP=382	GT	0/1
chr3	195505960	195505960	G	C	exonic	MUC4	.	nonsynonymous SNV	MUC4:NM_018406:exon2:c.C12491G:p.T4164S	.	.	.	.	0.37408	.	6.320387277	99.8643548	14250.21522	26.01128	0.291	0.149	T	0.613	0.378	P	0.213	0.357	B	.	.	.	1.000	0.588	D	.	.	.	1.38	0.358	T	-0.6	0.206	N	0.047	0.028	-1.047	0.153	T	0.046	0.198	T	.	.	.	-0.520	0.054	0.196	0.420	0.030	0.014	0.046	N	c	-1.001	-1.186	0.000	0.029	0.554	0.283	0	.	.	0.464	0.215	0.174	0.246	0.000	0.063	0.005	0.090	5.853	0.178	.	.	.	0.5	173	325	chr3	195505960	chr3:195505960	G	C	173	PASS	AN=2;DP=325	GT	0/1
chr4	2460571	2460571	C	T	exonic	CFAP99	.	nonsynonymous SNV	CFAP99:NM_001193282:exon12:c.C1283T:p.A428V	.	.	.	.	.	.	.	.	.	.	0.561	0.063	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.05	0.078	N	0.034	0.014	-0.952	0.406	T	0.000	0.000	T	.	.	.	0.663	0.157	8.585	0.870	0.163	0.031	0.080	N	c	-0.964	-1.035	1.000	0.747	0.581	0.326	0	0.034	0.134	1.083	0.302	-0.858	0.029	0.764	0.290	0.005	0.090	0.910	0.012	.	ENSG00000206113.3|ENSG00000159733.9|ENSG00000159733.9	Colon_Transverse|Lung|Whole_Blood	0.5	118	77	chr4	2460571	chr4:2460571	C	T	118	PASS	AN=2;DP=77	GT	0/1
chr4	4864485	4864485	G	T	exonic	MSX1	.	nonsynonymous SNV	MSX1:NM_002448:exon2:c.G527T:p.R176L	0.275361731	0.633641369	0.090996899	DISEASE: Tooth agenesis selective 1 (STHAG1) [MIM:106600]: A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). Tooth agenesis selective type 1 can be associated with orofacial cleft in some patients. {ECO:0000269|PubMed:12097313, ECO:0000269|PubMed:8696335}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=MSX1 is deleted in some patients with Wolf- Hirschhorn syndrome (WHS). WHS results from sub-telomeric deletions in the short arm of chromosome 4. {ECO:0000305|PubMed:1969845}.; DISEASE: Ectodermal dysplasia 3, Witkop type (ECTD3) [MIM:189500]: A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures such as hair, teeth, nails and sweat glands, with or without any additional clinical sign. Each combination of clinical features represents a different type of ectodermal dysplasia. ECTD3 is characterized by abnormalities largely limited largely to teeth (some of which are missing) and nails (which are poorly formed early in life, especially toenails). This condition is distinguished from anhidrotic ectodermal dysplasia by autosomal dominant inheritance and little involvement of hair and sweat glands. The teeth are not as severely affected. {ECO:0000269|PubMed:11369996}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Non-syndromic orofacial cleft 5 (OFC5) [MIM:608874]: A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum. {ECO:0000269|PubMed:12807959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83114	0.60631	.	.	590.93175	4.92812	0.001	0.784	D	0.999	0.764	D	0.995	0.818	D	0.000	0.843	D	1	0.810	D	3.825	0.957	H	-5.5	0.991	D	-6.31	0.908	D	0.973	0.974	1.010	0.974	D	0.986	0.996	D	0.494	0.951	D	6.872	0.930	33	0.998	0.907	0.988	0.863	D	c	1.006	0.883	1.0	0.983	0.765	0.991	0	4.84	0.620	9.823	0.983	1.048	0.713	1.000	0.715	0.985	0.512	18.326	0.902	Homeobox domain|Homeodomain-like	.	.	0.5	76	138	chr4	4864485	chr4:4864485	G	T	76	PASS	AN=2;DP=138	GT	0/1
chr4	8305930	8305930	G	C	exonic	HTRA3	.	nonsynonymous SNV	HTRA3:NM_053044:exon8:c.G1120C:p.A374P	1.72E-05	0.675145167	0.324837634	.	0.16158	0.11489	-0.822919685	11.76574664	170.60666	2.84944	0.272	0.159	T	0.172	0.271	B	0.063	0.256	B	0.091	0.203	N	0.858	0.284	N	0.75	0.191	N	2.43	0.153	T	-0.61	0.181	N	0.291	0.350	-1.044	0.162	T	0.027	0.117	T	0.006	0.163	T	2.478	0.359	19.32	0.976	0.341	0.128	0.173	N	c	-0.352	-0.257	1.000	0.747	0.507	0.198	0	1.61	0.226	2.509	0.449	0.998	0.613	1.000	0.715	0.997	0.653	7.319	0.255	PDZ domain	.	.	0.5	137	134	chr4	8305930	chr4:8305930	G	C	137	PASS	AN=2;DP=134	GT	0/1
chr4	46994916	46994916	G	A	exonic	GABRA4	.	nonsynonymous SNV	GABRA4:NM_000809:exon2:c.C134T:p.T45I,GABRA4:NM_001204266:exon2:c.C77T:p.T26I,GABRA4:NM_001204267:exon2:c.C77T:p.T26I	0.981416569	0.018580722	2.71E-06	.	0.15547	0.13425	0.260991686	70.25831564	2958.52439	10.303	0.27	0.160	T	0.005	0.119	B	0.017	0.170	B	0.000	0.491	D	0.907	0.276	N	0	0.065	N	-1.46	0.810	T	-1.16	0.297	N	0.046	0.150	-0.847	0.522	T	0.243	0.612	T	0.032	0.543	D	2.022	0.304	16.35	0.996	0.748	0.942	0.603	D	c	-0.259	-0.031	1.000	0.517	0.583	0.331	0	4.61	0.566	7.139	0.767	0.998	0.613	1.000	0.715	0.999	0.750	11.618	0.502	.	.	.	0.5	85	127	chr4	46994916	chr4:46994916	G	A	85	PASS	AN=2;DP=127	GT	0/1
chr4	48485962	48485962	C	T	exonic	SLC10A4	.	synonymous SNV	SLC10A4:NM_152679:exon1:c.C384T:p.H128H	0.167299362	0.771814239	0.060886399	.	0.04161	.	.	.	57.29346	1.52517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	chr4	48485962	chr4:48485962	C	T	.	PASS	AN=0;DP=79	GT	0/1
chr4	107237814	107237814	C	T	UTR5	TBCK	NM_001163436:c.-7697G>A	.	.	3.22E-06	0.999352989	0.000643795	.	.	.	-0.042196577	50.49539986	1635.40912	7.4738	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	238	chr4	107237814	chr4:107237814	C	T	142	PASS	AN=2;DP=238	GT	0/1
chr4	151505075	151505075	C	A	exonic	MAB21L2	.	nonsynonymous SNV	MAB21L2:NM_006439:exon1:c.C894A:p.D298E	0.803779159	0.195111772	0.001109069	DISEASE: Microphthalmia, syndromic, 14 (MCOPS14) [MIM:615877]: A form of microphthalmia, a disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities. MCOPS14 patients exhibit bilateral colobomatous microphthalmia or bilateral anophthalmia. Intellectual disability and rhizomelic skeletal dysplasia is present in some affected individuals. {ECO:0000269|PubMed:24906020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.67997	0.12971	-0.339715008	30.06605331	10.58824	0.3852	0.24	0.177	T	0.507	0.354	P	0.366	0.416	B	0.000	0.843	D	1	0.810	D	2.22	0.631	M	3.06	0.087	T	-0.5	0.158	N	0.613	0.635	-1.056	0.128	T	0.020	0.082	T	0.012	0.299	T	1.489	0.241	13.25	0.963	0.288	0.930	0.568	D	c	-0.315	-0.241	1.000	0.747	0.623	0.393	0	1.46	0.217	0.817	0.267	0.065	0.171	0.999	0.424	0.999	0.750	12.396	0.545	Mab-21 domain|Ricin B, lectin domain	.	.	0.5	111	166	chr4	151505075	chr4:151505075	C	A	111	PASS	AN=2;DP=166	GT	0/1
chr4	153864407	153864407	T	C	exonic	FHDC1	.	synonymous SNV	FHDC1:NM_033393:exon1:c.T198C:p.L66L	0.024454127	0.975428958	0.000116915	.	0.39667	0.08948	0.969962249	90.20995518	6091.11428	16.31408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	177	245	chr4	153864407	chr4:153864407	T	C	177	PASS	AN=2;DP=245	GT	1/0
chr4	190878577	190878577	A	G	exonic	FRG1	.	nonsynonymous SNV	FRG1:NM_004477:exon6:c.A457G:p.N153D	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	0.004	0.654	D	0.481	0.349	P	0.6	0.489	P	0.000	0.843	D	1.000	0.588	D	2.56	0.750	M	1.75	0.505	T	-4.0	0.769	D	0.204	0.530	-0.731	0.589	T	0.247	0.616	T	.	.	.	4.427	0.593	24.2	0.993	0.572	0.982	0.800	D	c	0.095	0.054	1.000	0.427	0.707	0.730	0	2.99	0.335	7.501	0.803	0.136	0.221	1.000	0.715	0.992	0.562	8.215	0.305	Actin cross-linking	.	.	0.5	127	505	chr4	190878577	chr4:190878577	A	G	127	PASS	AN=2;DP=505	GT	0/1
chr4	190894317	190894317	A	C	intergenic	FRG1;FRG2	dist=9958;dist=51206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	361	chr4	190894317	chr4:190894317	A	C	139	PASS	AN=2;DP=361	GT	0/1
chr5	878461	878461	G	A	intronic	BRD9	.	.	.	0.249187874	0.749502264	0.001309862	.	0.12337	0.10817	-0.797234383	12.48525596	290.83161	3.64776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	123	chr5	878461	chr5:878461	G	A	135	PASS	AN=2;DP=123	GT	0/1
chr5	1320805	1320805	G	C	exonic	CLPTM1L	.	nonsynonymous SNV	CLPTM1L:NM_030782:exon16:c.C1458G:p.I486M	0.311319339	0.688524082	0.000156579	.	0.22539	0.12562	-0.596992387	18.18825195	148.89252	2.66142	0.0	0.912	D	1.0	0.899	D	0.994	0.916	D	0.000	0.843	D	1	0.810	D	3.175	0.890	M	0.0	0.626	T	-2.61	0.571	D	0.922	0.914	0.133	0.848	D	0.507	0.814	D	0.178	0.854	D	6.197	0.855	28.7	0.998	0.847	0.938	0.590	D	c	0.822	0.754	1.000	0.747	0.707	0.730	0	5.05	0.674	4.408	0.593	0.933	0.449	1.000	0.715	1.000	0.888	17.527	0.876	.	.	.	0.5	90	203	chr5	1320805	chr5:1320805	G	C	90	PASS	AN=2;DP=203	GT	0/1
chr5	7304281	7304281	T	A	ncRNA_intronic	LOC442132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	291	chr5	7304281	chr5:7304281	T	A	75	PASS	AN=2;DP=291	GT	0/1
chr5	14652316	14652316	C	T	downstream	SNORD141A;SNORD141B	dist=71	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	425	chr5	14652316	chr5:14652316	C	T	101	PASS	AN=2;DP=425	GT	0/1
chr5	17273722	17273722	A	C	intronic	BASP1	.	.	.	0.539222353	0.403650733	0.057126915	.	0.20195	0.13818	.	.	157.19188	2.73957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	165	287	chr5	17273722	chr5:17273722	A	C	165	PASS	AN=2;DP=287	GT	0/1
chr5	35065313	35065313	G	T	exonic	PRLR	.	nonsynonymous SNV	PRLR:NM_001204314:exon7:c.C1444A:p.L482I,PRLR:NM_000949:exon10:c.C1747A:p.L583I	0.916128016	0.083848214	2.38E-05	DISEASE: Multiple fibroadenomas of the breast (MFAB) [MIM:615554]: A benign breast disease marked by lobuloalveolar growth with abnormally high proliferation of the epithelium, and characterized by the presence of more than 3 fibroadenomas in one breast. Fibroadenomas are adenomas containing fibrous tissue. {ECO:0000269|PubMed:18779591}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hyperprolactinemia (HPRL) [MIM:615555]: A disorder characterized by increased levels of prolactin in the blood not associated with gestation or the puerperium. HPRL may result in infertility, hypogonadism, and galactorrhea. {ECO:0000269|PubMed:24195502}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07595	0.38344	0.020302773	55.60863411	347.86975	3.95295	0.131	0.266	T	0.745	0.443	P	0.231	0.429	B	0.354	0.043	N	1	0.090	N	2.19	0.618	M	-2.44	0.888	D	-0.52	0.162	N	0.086	0.092	-0.423	0.713	T	0.651	0.879	D	0.090	0.756	D	-0.605	0.050	0.121	0.935	0.227	0.108	0.160	N	c	-0.450	-0.585	0.103	0.164	0.554	0.283	0	1.92	0.248	0.448	0.213	0.953	0.551	0.000	0.063	0.498	0.270	9.175	0.361	.	.	.	0.5	116	180	chr5	35065313	chr5:35065313	G	T	116	PASS	AN=2;DP=180	GT	0/1
chr5	41904406	41904406	G	T	upstream	C5orf51	dist=40	.	.	0.0038889	0.957830834	0.038280267	.	.	.	0.104848986	61.49445624	180.03222	2.91542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	194	chr5	41904406	chr5:41904406	G	T	132	PASS	AN=2;DP=194	GT	0/1
chr5	85582748	85582748	A	G	ncRNA_exonic	NBPF22P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	276	chr5	85582748	chr5:85582748	A	G	150	PASS	AN=2;DP=276	GT	0/1
chr5	92923754	92923754	C	A	exonic	NR2F1	.	nonsynonymous SNV	NR2F1:NM_005654:exon2:c.C595A:p.P199T	.	.	.	DISEASE: Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722]: An autosomal dominant disorder characterized by optic atrophy associated with developmental delay and intellectual disability. Most patients also have evidence of cerebral visual impairment. {ECO:0000269|PubMed:24462372}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.7496	0.11262	-0.339715008	30.06605331	3.34161	0.12228	0.03	0.453	D	0.997	0.689	D	0.975	0.717	D	0.000	0.843	D	1	0.810	D	1.57	0.397	L	0.72	0.510	T	-5.94	0.891	D	0.644	0.660	-0.669	0.619	T	0.274	0.646	T	0.045	0.621	D	2.325	0.341	18.33	0.997	0.823	0.996	0.981	D	c	0.524	0.446	1.000	0.747	0.707	0.730	0	4.5	0.542	7.879	0.856	0.932	0.445	1.000	0.715	0.971	0.463	17.383	0.872	Nuclear hormone receptor, ligand-binding domain	.	.	0.5	119	188	chr5	92923754	chr5:92923754	C	A	119	PASS	AN=2;DP=188	GT	0/1
chr5	99728376	99728376	C	T	intergenic	LOC100133050;FAM174A	dist=4418;dist=142633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	280	chr5	99728376	chr5:99728376	C	T	127	PASS	AN=2;DP=280	GT	0/1
chr5	116052145	116052145	C	T	intergenic	SEMA6A-AS2;LINC02214	dist=105249;dist=26853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	147	chr5	116052145	chr5:116052145	C	T	101	PASS	AN=2;DP=147	GT	0/1
chr5	127593605	127593605	C	A	UTR3	FBN2	NM_001999:c.*1542G>T	.	.	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	229	chr5	127593605	chr5:127593605	C	A	128	PASS	AN=2;DP=229	GT	0/1
chr5	133707247	133707247	-	T	UTR5	UBE2B	NM_003337:c.-40_-39insT	.	.	0.320977559	0.662551081	0.01647136	.	0.5202	0.16306	0.013025609	54.62962963	1.48948	0.0507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	114	chr5	133707247	chr5:133707247	C	CT	94	PASS	AN=2;DP=114	GT	0/1
chr5	140165915	140165915	C	T	exonic	PCDHA1	.	synonymous SNV	PCDHA1:NM_018900:exon1:c.C40T:p.L14L,PCDHA1:NM_031410:exon1:c.C40T:p.L14L,PCDHA1:NM_031411:exon1:c.C40T:p.L14L	0.000559475	0.973083018	0.026357507	.	0.08763	.	0.213053688	67.54541165	435.99793	4.35381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	190	chr5	140165915	chr5:140165915	C	T	137	PASS	AN=2;DP=190	GT	0/1
chr5	140167202	140167202	G	A	exonic	PCDHA1	.	nonsynonymous SNV	PCDHA1:NM_018900:exon1:c.G1327A:p.V443M,PCDHA1:NM_031410:exon1:c.G1327A:p.V443M,PCDHA1:NM_031411:exon1:c.G1327A:p.V443M	0.000559475	0.973083018	0.026357507	.	0.08763	.	0.213053688	67.54541165	435.99793	4.35381	0.0	0.912	D	1.0	0.899	D	0.998	0.875	D	0.002	0.371	U	0.856	0.284	N	3.335	0.911	M	-0.68	0.726	T	-2.76	0.605	D	0.633	0.674	-0.087	0.804	T	0.577	0.848	D	0.045	0.621	D	5.444	0.738	26.1	0.998	0.923	0.884	0.481	D	c	0.610	0.462	0.977	0.297	0.581	0.326	0	3.89	0.439	3.871	0.555	0.953	0.551	1.000	0.715	0.893	0.376	8.718	0.334	Cadherin|Cadherin conserved site|Cadherin-like	.	.	0.5	.	138	chr5	140167202	chr5:140167202	G	A	.	PASS	AN=0;DP=138	GT	0/1
chr5	176930231	176930231	C	G	exonic	DOK3	.	nonsynonymous SNV	DOK3:NM_001144876:exon5:c.G502C:p.E168Q,DOK3:NM_001144875:exon6:c.G808C:p.E270Q	7.28E-05	0.743816689	0.256110523	.	0.16443	0.09799	-0.08265057	47.20452937	503.42172	4.60415	0.0	0.912	D	0.914	0.518	P	0.483	0.517	P	.	.	.	1	0.090	N	.	.	.	0.63	0.542	T	-0.4	0.138	N	0.022	0.005	-1.059	0.120	T	0.099	0.369	T	0.010	0.268	T	0.367	0.129	6.323	0.993	0.574	0.067	0.126	N	c	-0.725	-0.837	1.000	0.747	0.722	0.854	0	2.4	0.284	-0.378	0.074	0.461	0.278	0.000	0.063	0.005	0.090	8.393	0.315	IRS-type PTB domain|PH domain-like;PH domain-like|Pleckstrin homology domain	.	.	0.5	108	102	chr5	176930231	chr5:176930231	C	G	108	PASS	AN=2;DP=102	GT	0/1
chr6	52664027	52664027	C	A	exonic	GSTA1	.	synonymous SNV	GSTA1:NM_145740:exon2:c.G39T:p.R13R	0.059010542	0.867804347	0.073185111	.	0.05662	.	-0.181750739	40.15687662	74.35516	1.80096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	189	chr6	52664027	chr6:52664027	C	A	91	PASS	AN=2;DP=189	GT	0/1
chr6	80775100	80775100	A	T	intergenic	TTK;BCKDHB	dist=22856;dist=41227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	297	chr6	80775100	chr6:80775100	A	T	139	PASS	AN=2;DP=297	GT	0/1
chr6	109001232	109001232	C	T	UTR3	FOXO3	NM_201559:c.*237C>T;NM_001455:c.*237C>T	.	.	.	.	.	DISEASE: Note=A chromosomal aberration involving FOXO3 is found in secondary acute leukemias. Translocation t(6;11)(q21;q23) with KMT2A/MLL1.; 	.	0.59462	-0.492218069	22.35786742	267.4981	3.50708	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	156	chr6	109001232	chr6:109001232	C	T	125	PASS	AN=2;DP=156	GT	0/1
chr6	133135715	133135715	C	A	UTR5	RPS12	NM_001016:c.-193C>A	.	.	0.827435142	0.168866928	0.00369793	.	0.26171	0.19444	0.035072054	56.2514744	9.87588	0.36197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	169	chr6	133135715	chr6:133135715	C	A	113	PASS	AN=2;DP=169	GT	0/1
chr6	136582417	136582417	G	A	exonic	BCLAF1	.	nonsynonymous SNV	BCLAF1:NM_001077440:exon11:c.C2590T:p.R864C,BCLAF1:NM_001077441:exon12:c.C2224T:p.R742C,BCLAF1:NM_001301038:exon12:c.C2737T:p.R913C,BCLAF1:NM_014739:exon12:c.C2743T:p.R915C	.	.	.	.	0.85841	0.18154	1.987926294	97.63505544	3652.78199	11.74717	0.032	0.469	D	1.0	0.899	D	0.988	0.850	D	0.000	0.629	D	1.000	0.588	D	0	0.065	N	4.26	0.161	T	-1.2	0.320	N	0.874	0.863	-0.997	0.309	T	0.084	0.329	T	.	.	.	4.562	0.611	24.4	0.992	0.542	0.972	0.729	D	c	0.262	0.417	1.000	0.747	0.707	0.730	0	5.71	0.890	5.465	0.662	1.048	0.713	1.000	0.715	1.000	0.888	18.034	0.892	.	.	.	0.5	96	137	chr6	136582417	chr6:136582417	G	A	96	PASS	AN=2;DP=137	GT	0/1
chr6	167709636	167709636	G	A	exonic	UNC93A	.	nonsynonymous SNV	UNC93A:NM_001143947:exon3:c.G386A:p.R129H,UNC93A:NM_018974:exon3:c.G386A:p.R129H	1.38E-06	0.610062547	0.389936076	.	0.08771	0.10097	2.53746678	98.71431941	4005.17839	12.52307	0.123	0.275	T	0.01	0.144	B	0.022	0.184	B	0.044	0.019	N	1	0.090	N	-0.17	0.043	N	1.51	0.309	T	-1.41	0.348	N	0.083	0.227	-1.058	0.123	T	0.011	0.040	T	0.001	0.018	T	-1.025	0.031	0.014	0.910	0.197	0.056	0.114	N	c	-2.069	-2.096	0.804	0.242	0.487	0.133	0	-5.73	0.022	-0.262	0.086	-1.772	0.007	0.000	0.063	0.000	0.016	0.985	0.013	Major facilitator superfamily domain	.	.	0.5	89	133	chr6	167709636	chr6:167709636	G	A	89	PASS	AN=2;DP=133	GT	0/1
chr7	2296436	2296436	C	A	intronic	SNX8	.	.	.	0.165170969	0.831782233	0.003046798	.	0.16684	0.11365	0.376678994	75.50719509	357.15648	4.00401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	79	chr7	2296436	chr7:2296436	C	A	95	PASS	AN=2;DP=79	GT	0/1
chr7	5959485	5959485	G	A	exonic	CCZ1	.	nonsynonymous SNV	CCZ1:NM_015622:exon12:c.G994A:p.V332I	0.994694688	0.005304692	6.20E-07	.	0.2029	.	-0.159704656	41.90846898	84.72538	1.9605	0.44	0.092	T	0.001	0.067	B	0.004	0.093	B	0.045	0.236	N	1	0.090	P	.	.	.	.	.	.	-0.17	0.096	N	0.043	0.023	-1.016	0.249	T	0.000	0.000	T	.	.	.	-1.013	0.031	0.015	0.631	0.069	0.021	0.061	N	c	-1.612	-1.668	0.000	0.057	0.706	0.609	0	-5.07	0.027	0.961	0.287	-0.569	0.046	0.134	0.232	0.001	0.043	9.832	0.399	.	ENSG00000122674.8	Colon_Transverse	0.5	151	366	chr7	5959485	chr7:5959485	G	A	151	PASS	AN=2;DP=366	GT	0/1
chr7	6899511	6899511	C	A	intergenic	CCZ1B;MIR3683	dist=33585;dist=207084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	chr7	6899511	chr7:6899511	C	A	.	PASS	AN=0;DP=112	GT	0/1
chr7	12668752	12668752	G	T	exonic	SCIN	.	nonsynonymous SNV	SCIN:NM_033128:exon7:c.G483T:p.R161S,SCIN:NM_001112706:exon9:c.G1224T:p.R408S	4.08E-16	0.001532187	0.998467813	.	0.49689	0.12425	1.223576934	93.23543289	4912.87103	14.2979	0.074	0.346	T	0.903	0.478	P	0.648	0.505	P	0.000	0.843	D	0.996	0.431	D	2.195	0.620	M	2.44	0.152	T	-2.37	0.522	N	0.35	0.707	-1.117	0.025	T	0.053	0.226	T	0.018	0.406	T	3.101	0.432	22.5	0.991	0.522	0.629	0.317	D	c	-0.099	-0.212	0.017	0.129	0.638	0.428	0	0.542	0.163	0.884	0.277	0.154	0.240	0.459	0.264	0.112	0.193	7.923	0.288	ADF-H/Gelsolin-like domain|Gelsolin-like domain	.	.	0.5	116	88	chr7	12668752	chr7:12668752	G	T	116	PASS	AN=2;DP=88	GT	0/1
chr7	21467955	21467955	C	T	intronic	SP4	.	.	.	0.951288043	0.04870596	6.00E-06	.	0.90308	0.23101	-0.844966979	11.1759849	141.72587	2.59835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	356	chr7	21467955	chr7:21467955	C	T	85	PASS	AN=2;DP=356	GT	0/1
chr7	23625204	23625204	C	T	ncRNA_exonic	CLK2P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	227	chr7	23625204	chr7:23625204	C	T	123	PASS	AN=2;DP=227	GT	0/1
chr7	28547355	28547355	G	T	exonic	CREB5	.	synonymous SNV	CREB5:NM_182899:exon3:c.G192T:p.R64R,CREB5:NM_004904:exon4:c.G270T:p.R90R,CREB5:NM_182898:exon4:c.G291T:p.R97R	0.989844565	0.010154821	6.14E-07	.	0.7763	.	-0.670411825	15.61689078	30.64753	0.97477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	152	chr7	28547355	chr7:28547355	G	T	97	PASS	AN=2;DP=152	GT	0/1
chr7	48965281	48965281	G	T	ncRNA_exonic	CDC14C	.	.	.	.	.	.	.	.	0.09972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	300	chr7	48965281	chr7:48965281	G	T	120	PASS	AN=2;DP=300	GT	0/1
chr7	56877090	56877090	G	A	ncRNA_exonic	LOC401357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	161	270	chr7	56877090	chr7:56877090	G	A	161	PASS	AN=2;DP=270	GT	0/1
chr7	63020733	63020733	C	G	intergenic	LOC100287834;MIR4283-1	dist=161314;dist=60735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	70	chr7	63020733	chr7:63020733	C	G	.	PASS	AN=0;DP=70	GT	0/1
chr7	63033363	63033363	G	T	intergenic	LOC100287834;MIR4283-1	dist=173944;dist=48105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	144	chr7	63033363	chr7:63033363	G	T	66	PASS	AN=2;DP=144	GT	0/1
chr7	63720706	63720706	C	A	exonic	ZNF679	.	stopgain	ZNF679:NM_153363:exon3:c.C147A:p.Y49X	1.43E-09	0.029818033	0.970181966	.	0.06744	.	1.903532842	97.3519698	2627.76478	9.6152	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6.635	0.910	32	0.981	0.377	0.009	0.034	N	c	-0.860	-1.269	0.000	0.029	0.487	0.133	0	-0.39	0.118	-1.105	0.034	-1.756	0.007	0.000	0.063	0.478	0.267	5.329	0.151	Krueppel-associated box	.	.	0.5	116	280	chr7	63720706	chr7:63720706	C	A	116	PASS	AN=2;DP=280	GT	0/1
chr7	72361246	72361246	A	T	UTR5	POM121	NM_001257190:c.-35705A>T;NM_172020:c.-35705A>T	.	.	.	.	.	.	0.2255	0.08649	-0.33061537	30.82094834	663.23352	5.16151	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	164	419	chr7	72361246	chr7:72361246	A	T	164	PASS	AN=2;DP=419	GT	0/1
chr7	72712011	72712011	T	A	intergenic	NCF1B;NSUN5	dist=62032;dist=4502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	114	chr7	72712011	chr7:72712011	T	A	96	PASS	AN=2;DP=114	GT	0/1
chr7	73814774	73814774	G	A	exonic	CLIP2	.	synonymous SNV	CLIP2:NM_032421:exon14:c.G2850A:p.R950R,CLIP2:NM_003388:exon15:c.G2955A:p.R985R	0.999881647	0.000118353	1.18E-11	DISEASE: Note=CLIP2 is located in the Williams-Beuren syndrome (WBS) critical region (PubMed:9799601). WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region. Haploinsufficiency of CLIP2 may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in the disease. However, it has been demonstrated that haploinsufficiency of this gene alone is not sufficient to cause any of the cognitive or facial features of WBS (PubMed:22608712). {ECO:0000305|PubMed:22608712, ECO:0000305|PubMed:9799601}.; 	0.13125	.	-1.186862251	5.90351498	632.85889	5.0685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	301	chr7	73814774	chr7:73814774	G	A	132	PASS	AN=2;DP=301	GT	0/1
chr7	74573036	74573036	C	G	ncRNA_intronic	NCF1C	.	.	.	.	.	.	.	0.17774	0.11639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	148	chr7	74573036	chr7:74573036	C	G	125	PASS	AN=2;DP=148	GT	0/1
chr7	74573061	74573061	G	-	ncRNA_exonic	NCF1C	.	.	.	.	.	.	.	0.17774	0.11639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	164	chr7	74573060	chr7:74573060	CG	C	119	PASS	AN=2;DP=164	GT	0/1
chr7	99905688	99905688	C	A	intronic	SPDYE3	.	.	.	0.825434138	0.173760887	0.000804975	.	.	.	.	.	7.34499	0.27357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	257	chr7	99905688	chr7:99905688	C	A	114	PASS	AN=2;DP=257	GT	0/1
chr7	100643308	100643308	C	T	exonic	MUC12	.	nonsynonymous SNV	MUC12:NM_001164462:exon2:c.C9464T:p.P3155L	.	.	.	.	0.09711	.	.	.	8273.45926	19.64989	0.003	0.682	D	.	.	.	.	.	.	.	.	.	1	0.090	N	1.04	0.263	L	2.47	0.149	T	-0.91	0.245	N	0.044	0.026	-0.967	0.378	T	0.019	0.079	T	0.009	0.229	T	1.208	0.211	11.79	0.496	0.042	0.007	0.031	N	c	-1.240	-1.397	0.000	0.029	0.638	0.428	0	-0.152	0.127	0.611	0.238	-0.415	0.060	0.001	0.137	0.000	0.016	5.189	0.144	.	.	.	0.5	.	603	chr7	100643308	chr7:100643308	C	T	.	PASS	AN=0;DP=603	GT	0/1
chr7	123334697	123334697	T	-	intronic	WASL	.	.	.	0.961960487	0.038036282	3.23E-06	.	0.89386	0.35187	-0.692458599	14.96815287	24.64068	0.80952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	169	106	chr7	123334696	chr7:123334696	GT	G	169	PASS	AN=2;DP=106	GT	1/0
chr7	128553004	128553004	C	-	intergenic	KCP;IRF5	dist=2231;dist=24082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	121	chr7	128553003	chr7:128553003	TC	T	120	PASS	AN=2;DP=121	GT	0/1
chr7	142231939	142231939	C	A	intergenic	TRY2P;MTRNR2L6	dist=259871;dist=142192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	115	chr7	142231939	chr7:142231939	C	A	106	PASS	AN=2;DP=115	GT	0/1
chr7	143453661	143453661	T	G	exonic	CTAGE6	.	nonsynonymous SNV	CTAGE6:NM_178561:exon1:c.A1091C:p.E364A	0.366836245	0.621526849	0.011636907	.	.	.	.	.	126.17664	2.44439	.	.	.	0.0	0.026	B	0.0	0.013	B	.	.	.	.	.	.	-3	0.000	N	3.5	0.050	T	.	.	.	0.041	0.021	.	.	.	.	.	.	.	.	.	-1.880	0.010	0.002	0.508	0.044	0.000	0.003	N	n	-0.640	-0.258	0.000	0.012	0.075	0.013	0	0.109	0.138	-0.293	0.083	-0.934	0.025	0.493	0.267	0.028	0.145	.	.	.	.	.	0.5	143	536	chr7	143453661	chr7:143453661	T	G	143	PASS	AN=2;DP=536	GT	0/1
chr7	149430875	149430875	G	C	exonic	KRBA1	.	unknown	UNKNOWN	1.47E-12	0.095501601	0.904498399	.	0.07786	.	.	.	814.97375	5.61027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	99	chr7	149430875	chr7:149430875	G	C	109	PASS	AN=2;DP=99	GT	0/1
chr7	149497462	149497462	C	A	exonic	SSPO	.	nonsynonymous SNV	SSPO:NM_198455:exon49:c.C7220A:p.A2407E	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	0.0	0.026	B	0.002	0.063	B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.115	0.126	.	.	.	.	.	.	.	.	.	1.592	0.253	13.81	0.879	0.170	0.023	0.066	N	n	0.827	2.765	0.857	0.251	0.070	0.012	0	-4.21	0.035	-1.105	0.034	-1.465	0.011	0.000	0.063	0.933	0.406	1.166	0.017	Low-density lipoprotein (LDL) receptor class A, conserved site	.	.	0.5	127	182	chr7	149497462	chr7:149497462	C	A	127	PASS	AN=2;DP=182	GT	0/1
chr7	151932916	151932916	C	G	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon16:c.G2755C:p.V919L	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.465	0.086	T	0.005	0.119	B	0.006	0.112	B	0.001	0.407	D	0.910	0.275	N	1.04	0.263	L	-1.76	0.836	D	-0.87	0.236	N	0.106	0.208	-0.782	0.562	T	0.290	0.662	T	.	.	.	1.682	0.263	14.31	0.935	0.226	0.885	0.481	D	c	-0.471	-0.289	0.000	0.060	0.737	0.974	0	3.05	0.341	0.914	0.280	0.892	0.403	0.989	0.365	1.000	0.888	9.075	0.355	.	.	.	0.5	144	446	chr7	151932916	chr7:151932916	C	G	144	PASS	AN=2;DP=446	GT	0/1
chr7	151936975	151936975	A	G	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	199	chr7	151936975	chr7:151936975	A	G	107	PASS	AN=2;DP=199	GT	0/1
chr7	157931119	157931119	A	G	exonic	PTPRN2	.	synonymous SNV	PTPRN2:NM_001308267:exon6:c.T885C:p.A295A,PTPRN2:NM_130842:exon6:c.T948C:p.A316A,PTPRN2:NM_001308268:exon7:c.T1068C:p.A356A,PTPRN2:NM_002847:exon7:c.T999C:p.A333A,PTPRN2:NM_130843:exon7:c.T999C:p.A333A	0.016557153	0.983434299	8.55E-06	DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus (IDDM). {ECO:0000269|PubMed:8637868, ECO:0000269|PubMed:8798755, ECO:0000269|PubMed:8878534}.; 	0.18753	0.09983	0.889106693	89.19556499	4454.24566	13.37565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	151	90	chr7	157931119	chr7:157931119	A	G	151	PASS	AN=2;DP=90	GT	0/1
chr8	3000078	3000078	G	T	exonic	CSMD1	.	synonymous SNV	CSMD1:NM_033225:exon41:c.C6150A:p.P2050P	.	.	.	.	0.20953	0.12394	-7.110830664	0.023590469	1048.09747	6.2145	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	80	chr8	3000078	chr8:3000078	G	T	69	PASS	AN=2;DP=80	GT	0/1
chr8	10480513	10480513	C	A	exonic	RP1L1	.	stopgain	RP1L1:NM_178857:exon2:c.G199T:p.E67X	.	.	.	DISEASE: Occult macular dystrophy (OCMD) [MIM:613587]: An inherited macular dystrophy characterized by progressive loss of macular function but normal ophthalmoscopic appearance. It is typically characterized by a central cone dysfunction leading to a loss of vision despite normal ophthalmoscopic appearance, normal fluorescein angiography, and normal full-field electroretinogram (ERGs), but the amplitudes of the focal macular ERGs and multifocal ERGs are significantly reduced at the central retina. {ECO:0000269|PubMed:20826268, ECO:0000269|PubMed:22605915}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09178	.	7.246646544	99.8997405	19576.13196	29.90294	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.943	0.979	38	0.998	0.866	0.987	0.861	D	c	1.005	0.829	1.000	0.517	0.554	0.283	0	4.78	0.605	3.787	0.549	0.934	0.450	0.998	0.411	0.995	0.604	16.962	0.861	Doublecortin domain	.	.	0.5	88	161	chr8	10480513	chr8:10480513	C	A	88	PASS	AN=2;DP=161	GT	0/1
chr8	68255399	68255399	C	T	exonic	ARFGEF1	.	nonsynonymous SNV	ARFGEF1:NM_006421:exon1:c.G124A:p.E42K	0.999999909	9.06E-08	1.03E-22	.	0.89864	0.2827	-1.745389579	2.37084218	294.25109	3.66374	0.081	0.334	T	0.615	0.379	P	0.269	0.381	B	0.000	0.629	N	1.000	0.520	D	1.805	0.477	L	2.05	0.207	T	-2.64	0.664	D	0.355	0.444	-1.113	0.028	T	0.061	0.253	T	0.138	0.821	D	3.589	0.489	23.2	0.998	0.926	0.874	0.466	D	c	0.312	0.350	1.000	0.747	0.442	0.072	0	3.95	0.448	7.418	0.792	0.824	0.337	1.000	0.715	0.959	0.439	12.942	0.576	Mon2, dimerisation and cyclophilin-binding domain	.	.	0.5	81	316	chr8	68255399	chr8:68255399	C	T	81	PASS	AN=2;DP=316	GT	0/1
chr8	101960934	101960934	C	A	exonic	YWHAZ	.	nonsynonymous SNV	YWHAZ:NM_001135699:exon2:c.G184T:p.V62F,YWHAZ:NM_001135700:exon2:c.G184T:p.V62F,YWHAZ:NM_001135701:exon2:c.G184T:p.V62F,YWHAZ:NM_001135702:exon2:c.G184T:p.V62F,YWHAZ:NM_003406:exon2:c.G184T:p.V62F,YWHAZ:NM_145690:exon2:c.G184T:p.V62F	0.817170005	0.181916765	0.00091323	.	0.99976	0.58572	0.079165051	59.43029016	1.06384	0.02718	0.0	0.912	D	0.987	0.600	D	0.748	0.541	P	0.000	0.629	D	1.000	0.810	D	2.105	0.586	M	0.83	0.478	T	-2.39	0.623	N	0.82	0.821	-0.773	0.567	T	0.189	0.541	T	0.050	0.642	D	6.470	0.892	29.9	0.997	0.785	0.960	0.667	D	c	0.461	0.497	1.000	0.747	0.672	0.522	0	5.51	0.817	0.788	0.263	0.935	0.490	0.858	0.303	1.000	0.888	19.492	0.950	14-3-3 domain	.	.	0.5	128	189	chr8	101960934	chr8:101960934	C	A	128	PASS	AN=2;DP=189	GT	0/1
chr8	106331252	106331252	C	A	intronic	ZFPM2	.	.	.	0.999955694	4.43E-05	5.33E-12	DISEASE: Tetralogy of Fallot (TOF) [MIM:187500]: A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis. {ECO:0000269|PubMed:14517948, ECO:0000269|PubMed:20807224}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Diaphragmatic hernia 3 (DIH3) [MIM:610187]: Form of congenital diaphragmatic hernia (CDH). CDH refers to a group of congenital defects in the structural integrity of the diaphragm associated with often lethal pulmonary hypoplasia and pulmonary hypertension. {ECO:0000269|PubMed:16103912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XY sex reversal 9 (SRXY9) [MIM:616067]: A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females or have ambiguous external genitalia. {ECO:0000269|PubMed:24549039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Conotruncal heart malformations (CTHM) [MIM:217095]: A group of congenital heart defects involving the outflow tracts. Examples include truncus arteriosus communis, double-outlet right ventricle and transposition of great arteries. Truncus arteriosus communis is characterized by a single outflow tract instead of a separate aorta and pulmonary artery. In transposition of the great arteries, the aorta arises from the right ventricle and the pulmonary artery from the left ventricle. In double outlet of the right ventricle, both the pulmonary artery and aorta arise from the right ventricle. {ECO:0000269|PubMed:20807224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.5623	0.26433	0.519883383	80.37272942	1899.90602	8.01507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	161	chr8	106331252	chr8:106331252	C	A	64	PASS	AN=2;DP=161	GT	0/1
chr8	109455823	109455823	C	T	UTR5	EMC2	NM_014673:c.-65C>T;NM_001329495:c.-2665C>T;NM_001329494:c.-65C>T;NM_001329493:c.-65C>T	.	.	8.61E-05	0.929791463	0.070122436	.	0.3077	0.11065	-0.09720619	46.20193442	9.46573	0.34895	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	129	chr8	109455823	chr8:109455823	C	T	69	PASS	AN=2;DP=129	GT	0/1
chr8	128428862	128428862	C	T	exonic	POU5F1B	.	stopgain	POU5F1B:NM_001159542:exon1:c.C751T:p.Q251X	7.27E-07	0.154902824	0.845096449	.	0.06534	.	.	.	6077.10056	16.28567	.	.	.	.	.	.	.	.	.	0.000	0.537	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8.918	0.960	35	0.986	0.430	0.241	0.221	N	c	0.201	-0.139	0.002	0.089	0.706	0.609	0	0.197	0.144	2.119	0.413	0.439	0.276	0.960	0.334	0.082	0.182	1.798	0.029	Homeobox domain|Homeodomain-like	.	.	0.5	109	204	chr8	128428862	chr8:128428862	C	T	109	PASS	AN=2;DP=204	GT	0/1
chr8	128806836	128806836	G	T	ncRNA_exonic	PVT1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	131	chr8	128806836	chr8:128806836	G	T	87	PASS	AN=2;DP=131	GT	0/1
chr9	52577	52577	G	A	intergenic	FAM138C;PGM5P3-AS1	dist=16713;dist=20113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	260	chr9	52577	chr9:52577	G	A	110	PASS	AN=2;DP=260	GT	0/1
chr9	52584	52584	C	T	intergenic	FAM138C;PGM5P3-AS1	dist=16720;dist=20106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	259	chr9	52584	chr9:52584	C	T	123	PASS	AN=2;DP=259	GT	0/1
chr9	21974695	21974695	G	T	exonic	CDKN2A	.	stopgain	CDKN2A:NM_000077:exon1:c.C132A:p.Y44X,CDKN2A:NM_001195132:exon1:c.C132A:p.Y44X,CDKN2A:NM_058197:exon1:c.C132A:p.Y44X	0.357648776	0.58984451	0.052506714	DISEASE: Note=The association between cutaneous and uveal melanomas in some families suggests that mutations in CDKN2A may account for a proportion of uveal melanomas. However, CDKN2A mutations are rarely found in uveal melanoma patients.; DISEASE: Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]: A malignant neoplasm of melanocytes, arising de novo or from a pre- existing benign nevus, which occurs most often in the skin but also may involve other sites. {ECO:0000269|PubMed:10651484, ECO:0000269|PubMed:10874641, ECO:0000269|PubMed:11506491, ECO:0000269|PubMed:12019208, ECO:0000269|PubMed:14646619, ECO:0000269|PubMed:19260062, ECO:0000269|PubMed:7987387, ECO:0000269|PubMed:8595405, ECO:0000269|PubMed:8653684, ECO:0000269|PubMed:8710906, ECO:0000269|PubMed:9328469, ECO:0000269|PubMed:9425228}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome (FAMMMPC) [MIM:606719]: An inherited cancer predisposition syndrome characterized by an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Li-Fraumeni syndrome (LFS) [MIM:151623]: Autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:10484981}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Melanoma-astrocytoma syndrome (MASTS) [MIM:155755]: Characterized by a dual predisposition to melanoma and neural system tumors, commonly astrocytoma. {ECO:0000269|PubMed:11136714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.03037	0.06846	0.725794416	85.98136353	20.60127	0.70067	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7.848	0.956	35	0.984	0.403	0.199	0.206	N	c	-0.369	-0.750	1.000	0.747	0.658	0.486	0	-2.57	0.059	-1.027	0.037	0.108	0.203	0.000	0.063	0.004	0.083	3.596	0.075	Ankyrin repeat-containing domain	.	.	0.5	.	63	chr9	21974695	chr9:21974695	G	T	.	PASS	AN=0;DP=63	GT	0/1
chr9	33290467	33290467	G	T	UTR5	NFX1	NM_147134:c.-104G>T;NM_001318758:c.-104G>T;NM_002504:c.-104G>T	.	.	0.386441239	0.613558732	2.94E-08	.	0.44031	.	-1.591018721	3.084453881	335.711	3.89158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	261	chr9	33290467	chr9:33290467	G	T	138	PASS	AN=2;DP=261	GT	0/1
chr9	33290474	33290474	G	T	UTR5	NFX1	NM_147134:c.-97G>T;NM_001318758:c.-97G>T;NM_002504:c.-97G>T	.	.	0.386441239	0.613558732	2.94E-08	.	0.44031	.	-1.591018721	3.084453881	335.711	3.89158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	285	chr9	33290474	chr9:33290474	G	T	134	PASS	AN=2;DP=285	GT	0/1
chr9	35713215	35713215	G	C	exonic	TLN1	.	synonymous SNV	TLN1:NM_006289:exon26:c.C3330G:p.A1110A	1	1.65E-12	2.92E-34	.	0.29532	0.38988	-3.420504246	0.365652276	1723.9194	7.6602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	60	chr9	35713215	chr9:35713215	G	C	.	PASS	AN=0;DP=60	GT	0/1
chr9	40332652	40332652	G	T	intergenic	FAM74A1;LOC105379450	dist=426433;dist=351167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	126	chr9	40332652	chr9:40332652	G	T	130	PASS	AN=2;DP=126	GT	0/1
chr9	67293607	67293607	T	C	ncRNA_exonic	LOC102724580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	177	427	chr9	67293607	chr9:67293607	T	C	177	PASS	AN=2;DP=427	GT	0/1
chr9	69634644	69634644	A	T	intergenic	LOC105379252;LOC100133920	dist=152967;dist=16717	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	246	chr9	69634644	chr9:69634644	A	T	.	PASS	AN=0;DP=246	GT	0/1
chr9	69847082	69847082	C	T	intergenic	LOC101928381;FOXD4L5	dist=89298;dist=328625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	161	436	chr9	69847082	chr9:69847082	C	T	161	PASS	AN=2;DP=436	GT	0/1
chr9	70993137	70993137	A	T	exonic	PGM5	.	nonsynonymous SNV	PGM5:NM_021965:exon2:c.A284T:p.Q95L	0.961611244	0.03838545	3.31E-06	.	0.47663	0.11828	-0.422438699	25.64284029	133.77721	2.51514	0.013	0.538	D	0.954	0.524	P	0.83	0.578	P	0.000	0.629	U	1	0.810	D	2.495	0.729	M	-0.04	0.633	T	-5.4	0.873	D	0.325	0.386	0.171	0.854	D	0.479	0.801	T	0.186	0.859	D	3.658	0.497	23.2	0.996	0.755	0.972	0.732	D	c	0.753	0.663	0.996	0.344	0.554	0.283	0	4.37	0.517	7.180	0.770	1.001	0.622	1.000	0.715	0.994	0.587	12.834	0.570	Alpha-D-phosphohexomutase, alpha/beta/alpha I/II/III|Alpha-D-phosphohexomutase, alpha/beta/alpha domain I	.	.	0.5	129	222	chr9	70993137	chr9:70993137	A	T	129	PASS	AN=2;DP=222	GT	0/1
chr9	82242418	82242418	G	T	intronic	TLE4	.	.	.	0.99992164	7.84E-05	4.33E-12	.	0.94973	0.14686	-0.556537043	19.72753008	90.91723	2.05178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	136	chr9	82242418	chr9:82242418	G	T	.	PASS	AN=0;DP=136	GT	0/1
chr9	99227651	99227651	T	C	exonic	HABP4	.	nonsynonymous SNV	HABP4:NM_014282:exon3:c.T545C:p.L182S	0.004932505	0.967203698	0.027863798	.	0.18355	0.11001	-0.560178693	19.30879925	16.2504	0.57669	0.098	0.308	T	0.974	0.559	D	0.462	0.447	P	0.524	0.117	N	1	0.090	N	1.7	0.440	L	1.42	0.332	T	-2.12	0.481	N	0.333	0.394	-1.024	0.223	T	0.057	0.238	T	0.014	0.333	T	0.843	0.174	9.729	0.986	0.428	0.118	0.167	N	c	-0.546	-0.639	0.733	0.231	0.732	0.924	0	-0.152	0.127	0.481	0.218	0.148	0.236	0.412	0.260	0.958	0.437	9.094	0.356	.	.	.	0.5	.	121	chr9	99227651	chr9:99227651	T	C	.	PASS	AN=0;DP=121	GT	0/1
chr9	101068579	101068579	C	T	exonic	GABBR2	.	nonsynonymous SNV	GABBR2:NM_005458:exon15:c.G2053A:p.A685T	0.999790263	0.000209737	9.64E-12	.	0.72097	0.15588	-1.285933373	5.083746167	1340.48679	6.87315	0.012	0.546	D	0.999	0.764	D	0.996	0.832	D	0.000	0.843	D	1	0.810	D	1.01	0.254	L	-2.26	0.874	D	-3.06	0.630	D	0.739	0.736	0.767	0.940	D	0.799	0.932	D	0.171	0.849	D	4.022	0.540	23.6	0.999	0.995	0.994	0.954	D	c	0.706	0.605	1.000	0.747	0.706	0.609	0	5.15	0.702	7.676	0.832	0.935	0.490	1.000	0.715	0.969	0.458	16.142	0.813	GPCR family 3, C-terminal	.	.	0.5	110	114	chr9	101068579	chr9:101068579	C	T	110	PASS	AN=2;DP=114	GT	0/1
chr9	102588038	102588038	G	T	UTR5	NR4A3	NM_006981:c.-2287G>T;NM_173200:c.-1015G>T;NM_173199:c.-2287G>T	.	.	.	.	.	DISEASE: Ewing sarcoma (ES) [MIM:612219]: A highly malignant, metastatic, primitive small round cell tumor of bone and soft tissue that affects children and adolescents. It belongs to the Ewing sarcoma family of tumors, a group of morphologically heterogeneous neoplasms that share the same cytogenetic features. They are considered neural tumors derived from cells of the neural crest. Ewing sarcoma represents the less differentiated form of the tumors. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving NR4A3 is found in patients with Erwing sarcoma. Translocation t(9;22)(q22- 31;q11-12) with EWSR1.; DISEASE: Note=A chromosomal aberration involving NR4A3 is a cause of a form of extraskeletal myxoid chondrosarcomas (EMC). Translocation t(9;17)(q22;q11) with TAF2N.; 	0.71461	0.18411	-0.339715008	30.06605331	1958.05838	8.14638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	103	chr9	102588038	chr9:102588038	G	T	102	PASS	AN=2;DP=103	GT	0/1
chr9	130279245	130279245	C	A	exonic	FAM129B	.	nonsynonymous SNV	FAM129B:NM_001035534:exon8:c.G825T:p.E275D,FAM129B:NM_022833:exon8:c.G864T:p.E288D	0.096703214	0.903283319	1.35E-05	.	0.24632	0.10776	-1.346642726	4.62962963	224.45345	3.23964	0.223	0.188	T	0.122	0.252	B	0.056	0.247	B	0.000	0.504	D	0.933	0.370	D	0.61	0.157	N	1.87	0.241	T	-0.87	0.236	N	0.08	0.072	-1.069	0.096	T	0.042	0.182	T	0.010	0.257	T	1.657	0.260	14.17	0.986	0.433	0.078	0.136	N	c	-0.549	-0.502	1.000	0.517	0.672	0.522	0	3.9	0.441	-0.708	0.051	0.016	0.142	0.063	0.217	0.021	0.135	7.542	0.268	.	.	.	0.5	109	154	chr9	130279245	chr9:130279245	C	A	109	PASS	AN=2;DP=154	GT	0/1
chr9	136412300	136412300	G	T	exonic	ADAMTSL2	.	nonsynonymous SNV	ADAMTSL2:NM_001145320:exon9:c.G904T:p.A302S,ADAMTSL2:NM_014694:exon9:c.G904T:p.A302S	0.071058667	0.916004048	0.012937285	DISEASE: Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]: An autosomal recessive disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone- shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues. {ECO:0000269|PubMed:18677313, ECO:0000269|PubMed:21415077}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26032	0.11516	.	.	74.41925	1.80297	0.0	0.912	D	1.0	0.899	D	0.984	0.745	D	0.002	0.372	N	1	0.810	D	1.455	0.369	L	0.56	0.546	T	-2.4	0.527	N	0.606	0.764	-0.625	0.638	T	0.310	0.681	T	0.024	0.468	T	4.603	0.617	24.4	0.998	0.850	0.989	0.883	D	c	0.695	0.670	1.000	0.747	0.646	0.450	0	5.16	0.704	9.847	0.984	1.048	0.713	1.000	0.715	0.997	0.653	18.645	0.913	ADAM-TS Spacer 1	.	.	0.5	87	196	chr9	136412300	chr9:136412300	G	T	87	PASS	AN=2;DP=196	GT	0/1
chr9	139840877	139840877	G	C	intronic	C8G	.	.	.	1.63E-09	0.032163822	0.967836176	.	0.04668	.	0.196671391	67.19155461	801.2629	5.57646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	118	chr9	139840877	chr9:139840877	G	C	.	PASS	AN=0;DP=118	GT	0/1
chr9	140343969	140343969	C	G	intronic	NSMF	.	.	.	0.046546174	0.95238468	0.001069146	DISEASE: Hypogonadotropic hypogonadism 9 with or without anosmia (HH9) [MIM:614838]: A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic- pituitary axis. In some cases, it is associated with non- reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). {ECO:0000269|PubMed:15362570, ECO:0000269|PubMed:21700882, ECO:0000269|PubMed:23643382}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. The genetics of hypogonadotropic hypogonadism involves various modes of transmission. Oligogenic inheritance has been reported in some patients carrying mutations in NSMF as well as in other HH-associated genes including FGFR1 (PubMed:23643382). {ECO:0000269|PubMed:23643382}.; 	0.15334	0.23802	-0.538132194	20.26421326	17.60779	0.61694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	163	chr9	140343969	chr9:140343969	C	G	84	PASS	AN=2;DP=163	GT	0/1
chr10	95108	95108	C	T	intronic	TUBB8	.	.	.	0.266953543	0.707835377	0.025211079	.	.	.	0.150760231	64.51403633	82.28258	1.92577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	188	chr10	95108	chr10:95108	C	T	92	PASS	AN=2;DP=188	GT	0/1
chr10	1779236	1779236	G	A	intronic	ADARB2	.	.	.	0.738168861	0.261726193	0.000104945	.	0.18882	0.14637	-0.505170032	21.79759377	584.19726	4.90127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	219	chr10	1779236	chr10:1779236	G	A	111	PASS	AN=2;DP=219	GT	0/1
chr10	30986286	30986286	G	C	ncRNA_intronic	SVILP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	257	chr10	30986286	chr10:30986286	G	C	103	PASS	AN=2;DP=257	GT	0/1
chr10	38682004	38682004	C	A	ncRNA_intronic	SEPT7P9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	chr10	38682004	chr10:38682004	C	A	.	PASS	AN=0;DP=112	GT	0/1
chr10	39011258	39011258	C	A	intergenic	ACTR3BP5;NONE	dist=19887;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	267	chr10	39011258	chr10:39011258	C	A	104	PASS	AN=2;DP=267	GT	0/1
chr10	42680959	42680959	C	A	intergenic	NONE;LOC441666	dist=NONE;dist=146355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	1246	chr10	42680959	chr10:42680959	C	A	122	PASS	AN=2;DP=1246	GT	0/1
chr10	42833142	42833142	A	T	ncRNA_exonic	LOC441666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	143	164	chr10	42833142	chr10:42833142	A	T	143	PASS	AN=2;DP=164	GT	0/1
chr10	42833154	42833154	T	C	ncRNA_exonic	LOC441666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	153	176	chr10	42833154	chr10:42833154	T	C	153	PASS	AN=2;DP=176	GT	0/1
chr10	42924593	42924593	G	-	ncRNA_exonic	CCNYL2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.85	115	chr10	42924592	chr10:42924592	AG	A	21.85	PASS	AN=0;DP=115	GT	0/1
chr10	43318544	43318544	T	G	intronic	BMS1	.	.	.	0.995287036	0.004712964	6.45E-12	DISEASE: Aplasia cutis congenita, non-syndromic (ACC) [MIM:107600]: A disorder characterized by congenital absence of a portion of skin in a localized or widespread area of the body. The lesions are most commonly localized on the scalp, however aplasia cutis congenita can affect any part of the body. {ECO:0000269|PubMed:23785305}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	0.099178678	60.75725407	2238.17745	8.72857	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	295	chr10	43318544	chr10:43318544	T	G	136	PASS	AN=2;DP=295	GT	0/1
chr10	47207792	47207792	C	G	intronic	AGAP9	.	.	.	.	.	.	.	0.08138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	1307	chr10	47207792	chr10:47207792	C	G	108	PASS	AN=2;DP=1307	GT	0/1
chr10	49791107	49791107	C	G	exonic	ARHGAP22	.	nonsynonymous SNV	ARHGAP22:NM_001256024:exon2:c.G125C:p.G42A,ARHGAP22:NM_001256025:exon2:c.G143C:p.G48A,ARHGAP22:NM_001347735:exon2:c.G125C:p.G42A,ARHGAP22:NM_001347737:exon2:c.G125C:p.G42A,ARHGAP22:NM_021226:exon2:c.G125C:p.G42A,ARHGAP22:NM_001347736:exon3:c.G143C:p.G48A,ARHGAP22:NM_001347738:exon3:c.G143C:p.G48A	0.000724652	0.980744858	0.01853049	.	0.12203	0.13515	-0.396754488	26.97570182	185.07105	2.95338	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1.000	0.588	D	3.81	0.956	H	-1.36	0.801	T	-4.73	0.800	D	0.464	0.732	0.820	0.947	D	0.781	0.926	D	0.206	0.871	D	5.863	0.803	27.3	0.998	0.928	0.993	0.936	D	c	0.987	0.894	1.000	0.747	0.707	0.730	0	5.28	0.740	7.531	0.807	0.935	0.490	1.000	0.715	0.916	0.392	17.462	0.875	PH domain-like|Pleckstrin homology domain	.	.	0.5	75	77	chr10	49791107	chr10:49791107	C	G	75	PASS	AN=2;DP=77	GT	0/1
chr10	50339798	50339798	C	A	exonic	FAM170B	.	stopgain	FAM170B:NM_001164484:exon2:c.G712T:p.E238X	.	.	.	.	0.14419	.	1.436808095	95.04600142	2513.30848	9.33771	.	.	.	.	.	.	.	.	.	0.002	0.383	N	1.000	0.520	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.868	0.964	36	0.994	0.614	0.403	0.262	N	c	0.451	0.247	1.000	0.517	0.497	0.185	0	2.64	0.304	2.607	0.457	0.935	0.490	0.942	0.325	0.990	0.544	7.549	0.268	.	.	.	0.5	75	102	chr10	50339798	chr10:50339798	C	A	75	PASS	AN=2;DP=102	GT	0/1
chr10	76994316	76994316	G	A	intronic	COMTD1	.	.	.	5.22E-06	0.245360812	0.754633963	.	0.23565	0.17097	.	.	97.13052	2.13085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	184	chr10	76994316	chr10:76994316	G	A	93	PASS	AN=2;DP=184	GT	0/1
chr10	81465992	81465992	T	A	exonic	NUTM2B	.	nonsynonymous SNV	NUTM2B:NM_001278495:exon2:c.T577A:p.C193S	0.841786847	0.155272462	0.002940691	.	.	.	.	.	421.0619	4.28418	0.471	0.084	T	.	.	.	.	.	.	.	.	.	1	0.090	N	0.345	0.112	N	2.01	0.213	T	0.45	0.043	N	0.093	0.092	-0.965	0.382	T	0.017	0.070	T	0.001	0.018	T	-1.849	0.010	0.002	0.285	0.015	0.003	0.016	N	c	-1.202	-1.417	0.000	0.012	0.554	0.246	0	-1.44	0.083	-1.628	0.021	-2.511	0.003	0.000	0.063	0.000	0.016	5.635	0.167	Nuclear Testis  protein, N-terminal	.	.	0.5	122	540	chr10	81465992	chr10:81465992	T	A	122	PASS	AN=2;DP=540	GT	0/1
chr10	89127071	89127071	A	T	intronic	NUTM2D	.	.	.	0.227557524	0.646694336	0.12574814	.	0.01294	.	.	.	4268.05044	12.98771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	322	chr10	89127071	chr10:89127071	A	T	118	PASS	AN=2;DP=322	GT	0/1
chr10	105881988	105881988	A	T	intronic	SFR1	.	.	.	0.000222755	0.506780782	0.492996463	.	0.0903	0.09372	-0.117432389	44.89266336	1205.57949	6.57654	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	399	chr10	105881988	chr10:105881988	A	T	129	PASS	AN=2;DP=399	GT	0/1
chr10	118927199	118927276	GGTCCCGGCGCCCGGCCTGTGTGGTGCTCAGATCAGACTTATCCACCCGAGCACCACGCAGACCAGCGCCTGGACCAA	-	ncRNA_exonic	MIR3663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	380	chr10	118927198	chr10:118927198	TGGTCCCGGCGCCCGGCCTGTGTGGTGCTCAGATCAGACTTATCCACCCGAGCACCACGCAGACCAGCGCCTGGACCAA	T	111	PASS	AN=2;DP=380	GT	0/1
chr10	124358490	124358490	G	T	exonic	DMBT1	.	stopgain	DMBT1:NM_004406:exon16:c.G1660T:p.G554X,DMBT1:NM_017579:exon25:c.G3127T:p.G1043X,DMBT1:NM_001320644:exon26:c.G3157T:p.G1053X,DMBT1:NM_007329:exon26:c.G3157T:p.G1053X	7.36E-32	0.326788431	0.673211569	DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note=The gene represented in this entry is involved in disease pathogenesis. Homozygous deletions may be the predominant mechanism of DMBT1 inactivation playing a role in carcinogenesis. DMBT1 is deleted in medulloblastoma and glioblastoma cell lines; point mutations have also been reported in patients with glioma. A loss or reduction of DMBT1 expression has been seen in esophageal, gastric, lung and colorectal carcinomas as well.; 	0.25445	.	4.221416241	99.71691437	3210.34948	10.79937	.	.	.	.	.	.	.	.	.	0.089	0.204	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.828	0.970	36	0.989	0.474	0.988	0.867	D	c	0.699	0.395	1.000	0.446	0.487	0.133	0	3.51	0.391	9.241	0.945	0.708	0.301	1.000	0.715	0.004	0.083	15.460	0.750	SRCR domain|SRCR-like domain	.	.	0.5	.	154	chr10	124358490	chr10:124358490	G	T	.	PASS	AN=0;DP=154	GT	0/1
chr10	135142432	135142432	C	A	exonic	CALY	.	nonsynonymous SNV	CALY:NM_015722:exon2:c.G62T:p.G21V	0.706613402	0.277792655	0.015593942	.	0.1537	0.13077	.	.	177.87988	2.8985	0.0	0.912	D	1.0	0.899	D	0.985	0.749	D	0.000	0.629	D	1.000	0.810	D	2.915	0.845	M	.	.	.	-5.47	0.904	D	0.651	0.771	-0.458	0.702	T	0.326	0.695	T	0.192	0.863	D	5.028	0.677	25.2	0.995	0.678	0.227	0.216	N	c	0.132	-0.057	0.997	0.354	0.598	0.340	0	2.62	0.302	0.230	0.175	0.047	0.160	0.010	0.182	0.020	0.134	6.860	0.231	.	.	.	0.5	86	169	chr10	135142432	chr10:135142432	C	A	86	PASS	AN=2;DP=169	GT	0/1
chr10	135372870	135372870	C	G	intronic	SYCE1	.	.	.	0.000763635	0.981995413	0.017240952	.	.	0.08486	1.374284246	94.51521585	1749.70499	7.72284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	93	chr10	135372870	chr10:135372870	C	G	144	PASS	AN=2;DP=93	GT	0/1
chr11	1221758	1221758	G	A	exonic	MUC5AC	.	unknown	UNKNOWN	.	.	.	.	0.15646	.	.	.	993.41134	6.07467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.23	0.897	M	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.865	0.177	9.861	0.799	0.125	0.913	0.531	D	n	1.251	1.181	1.000	0.747	0.078	0.016	0	4.48	0.538	3.067	0.495	0.951	0.538	1.000	0.715	0.049	0.163	14.439	0.667	Cystine knot, C-terminal	.	.	0.5	114	87	chr11	1221758	chr11:1221758	G	A	114	PASS	AN=2;DP=87	GT	0/1
chr11	2018440	2018440	G	A	ncRNA_exonic	H19	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	155	chr11	2018440	chr11:2018440	G	A	99	PASS	AN=2;DP=155	GT	0/1
chr11	2356603	2356603	T	C	ncRNA_intronic	CD81-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	110	chr11	2356603	chr11:2356603	T	C	137	PASS	AN=2;DP=110	GT	0/1
chr11	15134112	15134112	G	T	splicing	INSC	NM_001031853:exon1:c.96+1G>T	.	.	1.34E-09	0.338205484	0.661794515	.	0.24334	0.13495	0.892856963	89.28992687	1315.35282	6.81837	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.322	0.579	24.0	0.988	0.454	0.898	0.502	D	c	0.899	0.678	0.343	0.196	0.054	0.004	0	3.54	0.395	3.841	0.553	1.048	0.713	0.994	0.380	0.730	0.316	10.919	0.462	.	.	.	0.5	124	255	chr11	15134112	chr11:15134112	G	T	124	PASS	AN=2;DP=255	GT	0/1
chr11	19853946	19853946	A	T	intronic	NAV2	.	.	.	0.997517125	0.002482875	4.58E-16	.	0.41631	0.11088	-1.555318186	3.22009908	8281.16376	19.67042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	228	chr11	19853946	chr11:19853946	A	T	142	PASS	AN=2;DP=228	GT	0/1
chr11	49896515	49896515	C	T	intergenic	LOC440040;OR4C13	dist=64546;dist=77428	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	162	chr11	49896515	chr11:49896515	C	T	107	PASS	AN=2;DP=162	GT	0/1
chr11	55029751	55029751	G	TTCTATGTCCTTTAT	exonic	TRIM48	.	stopgain	TRIM48:NM_024114:exon1:c.8delinsTTCTATGTCCTTTAT:p.R3Lfs*5	1.77E-14	0.000532837	0.999467163	.	0.05186	.	1.840996754	97.08657702	499.24357	4.58752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	275	chr11	55029751	chr11:55029751	G	TTCTATGTCCTTTAT,GTCCTTTAT	72	PASS	AN=2;DP=275	GT	0/1
chr11	55029751	55029751	-	TCCTTTAT	exonic	TRIM48	.	stopgain	TRIM48:NM_024114:exon1:c.8_9insTCCTTTAT:p.R4Pfs*2	1.77E-14	0.000532837	0.999467163	.	0.05186	.	1.840996754	97.08657702	499.24357	4.58752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	275	chr11	55029751	chr11:55029751	G	TTCTATGTCCTTTAT,GTCCTTTAT	72	PASS	AN=2;DP=275	GT	0/1
chr11	55032505	55032505	C	A	exonic	TRIM48	.	nonsynonymous SNV	TRIM48:NM_024114:exon2:c.C174A:p.N58K	1.77E-14	0.000532837	0.999467163	.	0.05186	.	1.840996754	97.08657702	499.24357	4.58752	0.277	0.156	T	0.17	0.270	B	0.297	0.392	B	.	.	.	0.993	0.237	N	0.1	0.085	N	3.18	0.075	T	-1.66	0.397	N	0.163	0.196	-0.884	0.494	T	0.013	0.052	T	0.002	0.026	T	1.003	0.190	10.68	0.593	0.060	0.564	0.299	D	c	-0.813	-0.864	0.000	0.035	0.487	0.133	0	0.596	0.166	4.273	0.585	0.142	0.226	0.366	0.257	0.655	0.299	7.138	0.246	Zinc finger, RING/FYVE/PHD-type	.	.	0.5	135	122	chr11	55032505	chr11:55032505	C	A	135	PASS	AN=2;DP=122	GT	0/1
chr11	61537709	61537709	C	T	intronic	MYRF	.	.	.	0.999847803	0.000152197	4.41E-12	.	0.22352	0.1057	-1.082044518	7.242274121	229.21291	3.27206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	164	chr11	61537709	chr11:61537709	C	T	124	PASS	AN=2;DP=164	GT	0/1
chr11	62378331	62378331	T	A	intronic	EML3	.	.	.	0.394340909	0.605658415	6.76E-07	.	0.25723	0.09936	-0.843147538	11.2762444	758.07118	5.45547	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	114	chr11	62378331	chr11:62378331	T	A	144	PASS	AN=2;DP=114	GT	0/1
chr11	71822165	71822165	-	TGCTGGGGTCTCTGTCTA	intronic	ANAPC15	.	.	.	0.564413605	0.423423147	0.012163248	.	0.39459	0.11262	0.079165051	59.43029016	5.13875	0.19088	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	83	chr11	71822165	chr11:71822165	G	GTGCTGGGGTCTCTGTCTA	155	PASS	AN=2;DP=83	GT	1/0
chr11	72412608	72412608	C	T	ncRNA_intronic	ARAP1-AS2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	246	chr11	72412608	chr11:72412608	C	T	87	PASS	AN=2;DP=246	GT	0/1
chr11	73499066	73499066	-	GGGGAGATGGCGGACGGTGCAGAGA	intronic	MRPL48	.	.	.	0.138891985	0.841256691	0.019851324	.	0.11788	0.09364	0.014844891	54.94810097	193.07651	3.01163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	133	chr11	73499066	chr11:73499066	C	CGGGGAGATGGCGGACGGTGCAGAGA	57	PASS	AN=2;DP=133	GT	0/1
chr11	74875100	74875100	C	A	exonic	SLCO2B1	.	nonsynonymous SNV	SLCO2B1:NM_001145211:exon3:c.C174A:p.F58L,SLCO2B1:NM_007256:exon3:c.C240A:p.F80L	0.003353563	0.996214752	0.000431685	.	0.12048	0.17779	-0.483123186	22.78249587	2109.9785	8.45565	0.001	0.784	D	0.945	0.513	P	0.667	0.512	P	0.000	0.460	D	0.989	0.810	D	4.135	0.976	H	-0.09	0.641	T	-5.13	0.832	D	0.543	0.580	-0.231	0.769	T	0.356	0.719	T	0.158	0.839	D	5.636	0.768	26.6	0.993	0.579	0.179	0.198	N	c	-0.187	-0.389	1.000	0.500	0.549	0.223	0	-3.11	0.049	-2.095	0.014	-1.093	0.019	0.000	0.063	0.935	0.408	10.527	0.440	Major facilitator superfamily domain	.	.	0.5	112	193	chr11	74875100	chr11:74875100	C	A	112	PASS	AN=2;DP=193	GT	0/1
chr11	113668841	113668841	G	A	UTR3	USP28	NM_001301029:c.*1121C>T;NM_001346263:c.*1121C>T;NM_001346265:c.*1121C>T;NM_001346259:c.*1121C>T;NM_001346252:c.*1121C>T;NM_001346269:c.*1121C>T;NM_001346267:c.*1121C>T;NM_001346262:c.*1121C>T;NM_001346258:c.*1121C>T;NM_001346264:c.*1121C>T;NM_001346255:c.*1121C>T;NM_001346270:c.*1121C>T;NM_001346253:c.*1121C>T;NM_001346257:c.*1121C>T;NM_001346271:c.*1121C>T;NM_020886:c.*1121C>T;NM_001346272:c.*1121C>T;NM_001346261:c.*1121C>T;NM_001346268:c.*1121C>T;NM_001346254:c.*1121C>T;NM_001346260:c.*1121C>T	.	.	0.031657505	0.968342468	2.69E-08	.	0.60849	0.11751	-0.791786324	12.59731069	79.98741	1.89131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	312	chr11	113668841	chr11:113668841	G	A	137	PASS	AN=2;DP=312	GT	0/1
chr12	208258	208258	G	T	intronic	IQSEC3	.	.	.	0.925104239	0.074895032	7.29E-07	.	0.52569	.	-0.839512508	11.40009436	1171.33568	6.50545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	64	chr12	208258	chr12:208258	G	T	89	PASS	AN=2;DP=64	GT	0/1
chr12	2602441	2602441	C	A	exonic	CACNA1C	.	synonymous SNV	CACNA1C:NM_000719:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129827:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129829:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129830:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129831:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129832:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129833:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129834:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129835:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129836:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129837:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129838:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129839:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129840:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129841:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129842:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129843:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129844:exon7:c.C993A:p.P331P,CACNA1C:NM_001129846:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167623:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167624:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167625:exon7:c.C1002A:p.P334P,CACNA1C:NM_199460:exon7:c.C1002A:p.P334P	0.999998433	1.57E-06	4.37E-21	DISEASE: Timothy syndrome (TS) [MIM:601005]: Disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities and autism. {ECO:0000269|PubMed:15454078, ECO:0000269|PubMed:15863612, ECO:0000269|PubMed:25260352}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brugada syndrome 3 (BRGDA3) [MIM:611875]: A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66288	0.13071	-2.087541484	1.574663836	257.23512	3.4497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	160	chr12	2602441	chr12:2602441	C	A	94	PASS	AN=2;DP=160	GT	0/1
chr12	14650683	14650683	G	T	exonic	ATF7IP	.	nonsynonymous SNV	ATF7IP:NM_001286514:exon15:c.G3486T:p.K1162N,ATF7IP:NM_018179:exon15:c.G3489T:p.K1163N,ATF7IP:NM_181352:exon15:c.G3513T:p.K1171N	0.999741038	0.000258962	3.26E-12	.	0.67749	0.10619	0.473967469	78.86293937	7630.06967	18.76351	0.001	0.784	D	0.996	0.670	D	0.985	0.749	D	0.003	0.358	N	1.000	0.537	D	1.73	0.448	L	1.54	0.301	T	-3.3	0.658	D	0.451	0.504	-1.006	0.283	T	0.117	0.414	T	0.028	0.505	D	3.711	0.503	23.3	0.998	0.896	0.989	0.886	D	c	0.305	0.313	0.894	0.259	0.707	0.730	0	4.04	0.461	3.383	0.520	-0.197	0.102	1.000	0.715	0.998	0.697	9.328	0.370	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	102	206	chr12	14650683	chr12:14650683	G	T	102	PASS	AN=2;DP=206	GT	0/1
chr12	52841672	52841672	C	T	exonic	KRT6B	.	synonymous SNV	KRT6B:NM_005555:exon7:c.G1314A:p.K438K	0.004792655	0.966239227	0.028968117	.	0.12487	.	-0.304932527	32.24817174	532.75963	4.70795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	131	chr12	52841672	chr12:52841672	C	T	.	PASS	AN=0;DP=131	GT	0/1
chr12	53084970	53084970	G	T	exonic	KRT77	.	synonymous SNV	KRT77:NM_175078:exon9:c.C1716A:p.S572S	1.05E-06	0.785358392	0.214640555	.	0.11671	.	2.289361599	98.30738382	4908.5509	14.28597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	267	chr12	53084970	chr12:53084970	G	T	139	PASS	AN=2;DP=267	GT	0/1
chr12	57604120	57604120	G	A	exonic	LRP1	.	nonsynonymous SNV	LRP1:NM_002332:exon82:c.G12611A:p.C4204Y	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	0.0	0.912	D	0.998	0.715	D	0.991	0.782	D	0.000	0.843	D	1.000	0.588	D	4.215	0.979	H	1.6	0.286	T	-7.07	0.939	D	0.941	0.936	-0.201	0.777	T	0.288	0.660	T	0.036	0.571	D	6.395	0.883	29.6	0.991	0.528	0.923	0.551	D	c	0.905	0.797	1.000	0.747	0.672	0.522	0	4.44	0.530	7.637	0.823	1.048	0.713	1.000	0.715	1.000	0.888	16.366	0.831	EGF-like domain	.	.	0.5	62	47	chr12	57604120	chr12:57604120	G	A	62	PASS	AN=2;DP=47	GT	0/1
chr12	58090154	58090154	C	T	exonic	OS9	.	nonsynonymous SNV	OS9:NM_001261423:exon4:c.C400T:p.R134W,OS9:NM_001017956:exon5:c.C577T:p.R193W,OS9:NM_001017957:exon5:c.C577T:p.R193W,OS9:NM_001017958:exon5:c.C577T:p.R193W,OS9:NM_001261420:exon5:c.C577T:p.R193W,OS9:NM_006812:exon5:c.C577T:p.R193W	1.13E-07	0.933380259	0.066619628	.	.	.	-0.821100135	11.88369899	192.39758	3.00719	0.016	0.784	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.99	0.860	M	3.79	0.039	T	-4.9	0.902	D	0.81	0.900	-1.224	0.000	T	0.040	0.174	T	0.113	0.792	D	7.646	0.954	35	0.999	0.990	0.939	0.593	D	c	0.614	0.600	0.970	0.291	0.707	0.730	0	5.53	0.825	1.754	0.378	0.892	0.403	1.000	0.715	0.999	0.750	11.833	0.514	Glucosidase II beta subunit-like;Mannose-6-phosphate receptor binding domain	.	.	0.5	83	471	chr12	58090154	chr12:58090154	C	T	83	PASS	AN=2;DP=471	GT	0/1
chr12	66152389	66152389	G	T	ncRNA_exonic	RPSAP52	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	253	chr12	66152389	chr12:66152389	G	T	110	PASS	AN=2;DP=253	GT	0/1
chr12	70049190	70049190	C	T	exonic	BEST3	.	nonsynonymous SNV	BEST3:NM_152439:exon6:c.G865A:p.E289K,BEST3:NM_001282613:exon8:c.G1186A:p.E396K,BEST3:NM_032735:exon10:c.G1504A:p.E502K	3.69E-17	0.001380606	0.998619394	.	0.14764	0.10434	0.134171522	63.57041755	1059.3782	6.24526	0.001	0.784	D	0.999	0.764	D	0.994	0.807	D	0.075	0.212	N	0.647	0.810	D	1.935	0.520	L	-5.28	0.990	D	-1.1	0.326	N	0.471	0.686	1.082	0.989	D	0.967	0.990	D	0.354	0.924	D	4.793	0.643	24.7	0.999	0.935	0.937	0.586	D	c	0.206	0.110	1.000	0.747	0.487	0.133	0	4.6	0.564	4.645	0.609	-0.004	0.134	0.997	0.399	0.002	0.062	14.301	0.658	.	.	.	0.5	108	110	chr12	70049190	chr12:70049190	C	T	108	PASS	AN=2;DP=110	GT	0/1
chr12	78362403	78362403	G	T	exonic	NAV3	.	stopgain	NAV3:NM_001024383:exon5:c.G592T:p.E198X,NAV3:NM_014903:exon5:c.G592T:p.E198X	0.999999399	6.01E-07	4.23E-22	DISEASE: Note=A chromosomal aberration disrupting NAV3 has been found in patients with Sezary syndrome (PubMed:16166283). Translocation t(12;18)(q21;q21.2) (PubMed:16166283). {ECO:0000269|PubMed:16166283}.; 	0.8009	0.11717	-2.045202892	1.645435244	577.63321	4.87321	.	.	.	.	.	.	.	.	.	0.002	0.383	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.938	0.987	40	0.998	0.894	0.995	0.965	D	c	1.164	1.017	1.000	0.747	0.563	0.310	0	5.53	0.825	7.051	0.762	0.943	0.531	1.000	0.715	0.987	0.523	19.453	0.948	Calponin homology domain	.	.	0.5	114	69	chr12	78362403	chr12:78362403	G	T	114	PASS	AN=2;DP=69	GT	0/1
chr12	94975543	94975543	G	T	exonic	TMCC3	.	nonsynonymous SNV	TMCC3:NM_001301036:exon2:c.C757A:p.Q253K,TMCC3:NM_020698:exon2:c.C850A:p.Q284K	0.000392184	0.845537036	0.15407078	.	0.0962	0.10967	0.178263593	66.12998349	211.70761	3.13738	0.175	0.235	T	0.285	0.304	B	0.131	0.313	B	0.004	0.340	N	0.983	0.422	D	1.355	0.339	L	1.03	0.405	T	-1.45	0.356	N	0.368	0.429	-1.061	0.114	T	0.101	0.375	T	0.009	0.227	T	2.161	0.321	17.25	0.982	0.386	0.988	0.865	D	c	0.215	0.400	0.936	0.272	0.707	0.730	0	5.93	0.959	7.384	0.789	0.974	0.594	1.000	0.715	0.989	0.536	20.344	0.988	.	.	.	0.5	143	92	chr12	94975543	chr12:94975543	G	T	143	PASS	AN=2;DP=92	GT	0/1
chr13	29001292	29001292	C	A	intronic	FLT1	.	.	.	0.997806027	0.002193973	9.98E-13	DISEASE: Note=Can contribute to cancer cell survival, proliferation, migration, and invasion, and tumor angiogenesis and metastasis. May contribute to cancer pathogenesis by promoting inflammatory responses and recruitment of tumor-infiltrating macrophages.; DISEASE: Note=Abnormally high expression of soluble isoforms (isoform 2, isoform 3 or isoform 4) may be a cause of preeclampsia.; 	0.24106	0.64822	-1.521247944	3.44420854	121.53409	2.40056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	139	chr13	29001292	chr13:29001292	C	A	76	PASS	AN=2;DP=139	GT	0/1
chr13	38320457	38320457	G	T	exonic	TRPC4	.	nonsynonymous SNV	TRPC4:NM_001135955:exon3:c.C514A:p.H172N,TRPC4:NM_001135956:exon3:c.C514A:p.H172N,TRPC4:NM_001135957:exon3:c.C514A:p.H172N,TRPC4:NM_003306:exon3:c.C514A:p.H172N,TRPC4:NM_016179:exon3:c.C514A:p.H172N	0.967651076	0.032348906	1.79E-08	.	0.47812	.	-1.175687564	5.974286388	36.07747	1.08368	0.001	0.912	D	0.998	0.899	D	0.998	0.916	D	0.000	0.843	D	1	0.810	D	3.33	0.910	M	-0.74	0.803	T	-6.18	0.920	D	0.48	0.540	0.577	0.916	D	0.735	0.910	D	0.197	0.866	D	4.824	0.648	24.8	0.991	0.533	0.997	0.991	D	c	0.872	0.806	1.0	0.983	0.706	0.609	0	5.82	0.927	10.003	0.997	0.998	0.613	1.000	0.715	0.996	0.625	20.095	0.978	Ankyrin repeat-containing domain	.	.	0.5	69	236	chr13	38320457	chr13:38320457	G	T	69	PASS	AN=2;DP=236	GT	0/1
chr13	50366649	50366649	G	T	UTR5	KPNA3	NM_002267:c.-7C>A	.	.	0.809823934	0.190167527	8.54E-06	.	0.70799	0.22385	-0.117432389	44.89266336	63.49368	1.63216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	358	chr13	50366649	chr13:50366649	G	T	76	PASS	AN=2;DP=358	GT	0/1
chr13	100637893	100637893	G	T	exonic	ZIC2	.	nonsynonymous SNV	ZIC2:NM_007129:exon3:c.G1556T:p.G519V	.	.	.	DISEASE: Holoprosencephaly 5 (HPE5) [MIM:609637]: A structural anomaly of the brain, in which the developing forebrain fails to correctly separate into right and left hemispheres. Holoprosencephaly is genetically heterogeneous and associated with several distinct facies and phenotypic variability. {ECO:0000269|PubMed:11285244, ECO:0000269|PubMed:15221788, ECO:0000269|PubMed:19177455}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87813	0.23021	.	.	382.0785	4.12056	0.006	0.614	D	0.11	0.246	B	0.012	0.149	B	0.006	0.320	N	1.000	0.480	D	0.805	0.203	L	-1.22	0.788	T	-0.66	0.191	N	0.354	0.415	-0.658	0.624	T	0.265	0.636	T	0.850	0.988	D	3.223	0.447	22.7	0.981	0.380	0.790	0.388	D	c	-0.233	-0.118	1.000	0.517	0.543	0.218	0	2.81	0.318	4.421	0.594	0.779	0.314	1.000	0.715	0.991	0.552	10.976	0.465	.	.	.	0.5	113	150	chr13	100637893	chr13:100637893	G	T	113	PASS	AN=2;DP=150	GT	0/1
chr13	111371701	111371701	A	T	exonic	ING1	.	stopgain	ING1:NM_001267728:exon2:c.A211T:p.K71X,ING1:NM_005537:exon2:c.A691T:p.K231X,ING1:NM_198217:exon2:c.A130T:p.K44X,ING1:NM_198218:exon2:c.A55T:p.K19X,ING1:NM_198219:exon2:c.A262T:p.K88X	0.011435702	0.979963341	0.008600957	DISEASE: Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. {ECO:0000269|PubMed:10866301}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78935	0.17351	-0.512444034	21.55579146	154.20317	2.71419	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.978	0.988	40	0.995	0.707	0.991	0.918	D	c	0.884	0.760	1.000	0.747	0.632	0.406	0	5.14	0.699	8.731	0.912	1.053	0.755	1.000	0.715	1.000	0.888	14.967	0.707	Inhibitor of growth protein, N-terminal histone-binding	.	.	0.5	76	190	chr13	111371701	chr13:111371701	A	T	76	PASS	AN=2;DP=190	GT	0/1
chr14	20086244	20086244	G	A	intergenic	POTEM;OR11H2	dist=65972;dist=94819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	151	174	chr14	20086244	chr14:20086244	G	A	151	PASS	AN=2;DP=174	GT	0/1
chr14	21542838	21542838	G	A	exonic	ARHGEF40	.	nonsynonymous SNV	ARHGEF40:NM_018071:exon3:c.G949A:p.E317K	7.19E-05	0.999928131	1.25E-08	.	.	.	-0.226073511	37.1255013	1688.98262	7.57807	0.169	0.230	T	0.004	0.165	B	0.004	0.127	B	0.042	0.239	N	1	0.090	N	0	0.065	N	4.45	0.022	T	-0.36	0.221	N	0.126	0.290	-0.898	0.482	T	0.005	0.016	T	0.009	0.234	T	-0.348	0.065	0.516	0.816	0.133	0.137	0.178	N	c	-0.826	-0.745	0.997	0.355	0.632	0.406	0	4.23	0.492	2.765	0.471	1.048	0.713	0.115	0.229	0.034	0.151	11.400	0.489	.	.	.	0.5	91	217	chr14	21542838	chr14:21542838	G	A	91	PASS	AN=2;DP=217	GT	0/1
chr14	23315908	23315908	G	-	UTR3	MMP14	NM_004995:c.*660delG	.	.	0.987123657	0.01287612	2.23E-07	DISEASE: Winchester syndrome (WNCHRS) [MIM:277950]: A disease characterized by severe osteolysis in the hands and feet, generalized osteoporosis, bone thinning, and absence of subcutaneous nodules. Various additional features include coarse face, corneal opacities, gum hypertrophy, and EKG changes. {ECO:0000269|PubMed:22922033}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54891	0.55746	0.04598748	57.47817882	1317.7477	6.82691	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	165	98	chr14	23315907	chr14:23315907	AG	A	165	PASS	AN=2;DP=98	GT	0/1
chr14	23777193	23777193	G	T	exonic	BCL2L2;BCL2L2-PABPN1	.	nonsynonymous SNV	BCL2L2:NM_001199839:exon3:c.G217T:p.G73C,BCL2L2-PABPN1:NM_001199864:exon3:c.G217T:p.G73C,BCL2L2:NM_004050:exon3:c.G217T:p.G73C	.	.	.	.	.	.	.	.	.	.	0.052	0.682	T	0.592	0.556	P	0.281	0.677	B	0.000	0.473	D	0.562	0.461	N	2.095	0.583	M	2.66	0.126	T	-3.18	0.656	D	0.308	0.454	-0.824	0.537	T	0.136	0.452	T	0.031	0.535	D	4.130	0.554	23.8	0.996	0.724	0.971	0.723	D	c	0.021	0.101	1.000	0.747	0.660	0.490	0	4.94	0.645	4.022	0.567	1.048	0.713	1.000	0.715	1.000	0.888	12.745	0.565	.	.	.	0.5	145	347	chr14	23777193	chr14:23777193	G	T	145	PASS	AN=2;DP=347	GT	0/1
chr14	23829836	23829836	G	T	exonic	EFS	.	nonsynonymous SNV	EFS:NM_005864:exon2:c.C225A:p.S75R	2.45E-06	0.494202308	0.505795246	.	0.41116	0.14682	1.734373503	96.61476763	5246.98871	14.94057	0.358	0.120	T	0.004	0.112	B	0.002	0.063	B	0.117	0.192	N	1	0.810	D	2.005	0.547	M	1.95	0.225	T	-1.16	0.297	N	0.14	0.163	-1.066	0.103	T	0.032	0.138	T	0.003	0.077	T	0.906	0.180	10.11	0.950	0.253	0.321	0.243	N	c	-0.687	-0.628	1.000	0.747	0.632	0.408	0	3.16	0.353	0.726	0.255	1.048	0.713	0.002	0.151	0.950	0.426	5.295	0.150	SH3 domain	.	.	0.5	108	98	chr14	23829836	chr14:23829836	G	T	108	PASS	AN=2;DP=98	GT	0/1
chr14	31926571	31926571	G	C	exonic	DTD2	.	nonsynonymous SNV	DTD2:NM_080664:exon1:c.C29G:p.A10G	0.001708149	0.467463368	0.530828483	.	0.25961	0.07098	-0.053113545	49.38664779	6.20561	0.23402	0.079	0.344	T	0.476	0.348	P	0.132	0.314	B	0.008	0.310	N	1.000	0.548	D	2.24	0.636	M	0.27	0.592	T	-2.5	0.543	D	0.416	0.607	-0.768	0.570	T	0.181	0.528	T	0.045	0.617	D	3.890	0.524	23.5	0.996	0.726	0.947	0.619	D	c	-0.046	-0.001	1.0	0.983	0.442	0.072	0	4.09	0.469	6.242	0.721	0.079	0.188	1.000	0.715	0.362	0.248	12.504	0.551	D-Tyr tRNAtyr deacylase-like domain	.	.	0.5	150	463	chr14	31926571	chr14:31926571	G	C	150	PASS	AN=2;DP=463	GT	0/1
chr14	36988512	36988512	C	A	exonic	NKX2-1	.	nonsynonymous SNV	NKX2-1:NM_003317:exon1:c.G51T:p.L17F,NKX2-1:NM_001079668:exon2:c.G141T:p.L47F	0.081926486	0.871861122	0.046212392	DISEASE: Chorea, hereditary benign (BHC) [MIM:118700]: A rare autosomal dominant movement disorder, defined by early onset in childhood, a stable or non-progressive course of chorea, and no mental deterioration. Chorea is characterized by involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. {ECO:0000269|PubMed:11971878, ECO:0000269|PubMed:15955952}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction (CAHTP) [MIM:610978]: An autosomal dominant disorder that manifests in infancy with neurological disturbances, hypothyroidism, and respiratory problems. It is characterized by movement abnormalities beginning with muscular hypotonia followed by the development of chorea, athetosis, dystonia, ataxia, and dysarthria. {ECO:0000269|PubMed:11854318, ECO:0000269|PubMed:11854319, ECO:0000269|PubMed:15289765, ECO:0000269|PubMed:24714694}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.81487	0.52282	1.273147413	93.66595895	44.04874	1.26407	0.0	0.912	D	0.999	0.764	D	0.998	0.875	D	0.000	0.523	D	1	0.810	D	2.155	0.604	M	-0.95	0.754	T	-3.04	0.640	D	0.954	0.952	0.226	0.864	D	0.563	0.841	D	0.321	0.915	D	5.424	0.736	26.0	0.989	0.485	0.978	0.773	D	c	0.682	0.636	1.000	0.747	0.437	0.062	0	4.16	0.480	4.559	0.603	0.855	0.374	1.000	0.715	1.000	0.888	15.002	0.710	.	.	.	0.5	123	248	chr14	36988512	chr14:36988512	C	A	123	PASS	AN=2;DP=248	GT	0/1
chr14	45431332	45431332	T	C	upstream	KLHL28;TOGARAM1	dist=61	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	203	chr14	45431332	chr14:45431332	T	C	.	PASS	AN=0;DP=203	GT	0/1
chr14	59113339	59113339	G	C	exonic	DACT1	.	synonymous SNV	DACT1:NM_001079520:exon4:c.G1887C:p.V629V,DACT1:NM_016651:exon4:c.G1998C:p.V666V	0.816597553	0.183214244	0.000188203	DISEASE: Neural tube defects (NTD) [MIM:182940]: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components. {ECO:0000269|PubMed:22610794}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.15217	0.12544	0.202129237	67.42745931	2431.69074	9.16027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	191	chr14	59113339	chr14:59113339	G	C	.	PASS	AN=0;DP=191	GT	0/1
chr14	68039013	68039013	G	-	intronic	PLEKHH1	.	.	.	0.000660285	0.999338194	1.52E-06	.	0.14941	0.0838	1.256589163	93.48903043	7095.83143	18.11317	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.19	79	chr14	68039012	chr14:68039012	CG	C	13.19	PASS	AN=0;DP=79	GT	0/1
chr14	75388240	75388240	C	A	exonic	RPS6KL1	.	nonsynonymous SNV	RPS6KL1:NM_031464:exon2:c.G5T:p.S2I	0.000674281	0.9788712	0.020454519	.	0.10194	.	0.04598748	57.47817882	4892.98014	14.2268	0.0	0.912	D	0.998	0.715	D	0.991	0.807	D	0.011	0.298	N	0.993	0.238	N	2.39	0.691	M	0.01	0.625	T	-3.15	0.895	D	0.458	0.510	-0.860	0.513	T	0.248	0.617	T	0.061	0.683	D	5.601	0.763	26.5	0.995	0.703	0.788	0.386	D	c	0.270	0.224	1.000	0.458	0.660	0.495	0	3.26	0.363	2.273	0.428	0.852	0.362	1.000	0.715	0.781	0.330	6.163	0.195	.	.	.	0.5	81	121	chr14	75388240	chr14:75388240	C	A	81	PASS	AN=2;DP=121	GT	0/1
chr14	104573616	104573616	G	A	exonic	ASPG	.	nonsynonymous SNV	ASPG:NM_001080464:exon12:c.G1367A:p.R456K	1.18E-06	0.576666352	0.423332466	.	.	0.11691	0.560331224	81.70559094	4760.58672	13.97008	1.0	0.044	T	0.003	0.112	B	0.002	0.139	B	.	.	.	1	0.090	N	0.22	0.096	N	-0.11	0.645	T	-0.42	0.172	N	0.039	0.048	-1.015	0.253	T	0.097	0.365	T	0.047	0.630	D	-0.627	0.049	0.107	0.383	0.026	0.028	0.074	N	c	-1.176	-1.165	0.925	0.268	0.581	0.326	0	1.08	0.194	-0.215	0.092	1.029	0.652	0.000	0.063	0.025	0.141	5.347	0.152	Ankyrin repeat-containing domain	.	.	0.5	112	194	chr14	104573616	chr14:104573616	G	A	112	PASS	AN=2;DP=194	GT	0/1
chr14	104573618	104573618	-	TT	exonic	ASPG	.	frameshift insertion	ASPG:NM_001080464:exon12:c.1369_1370insTT:p.G457Vfs*4	1.18E-06	0.576666352	0.423332466	.	.	0.11691	0.560331224	81.70559094	4760.58672	13.97008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	195	chr14	104573618	chr14:104573618	G	GTT	108	PASS	AN=2;DP=195	GT	0/1
chr14	106725332	106725332	C	T	intergenic	ADAM6;LINC00226	dist=286974;dist=18937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	201	chr14	106725332	chr14:106725332	C	T	128	PASS	AN=2;DP=201	GT	0/1
chr15	20444807	20444807	C	A	intergenic	NONE;CHEK2P2	dist=NONE;dist=43190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	305	chr15	20444807	chr15:20444807	C	A	101	PASS	AN=2;DP=305	GT	0/1
chr15	20495286	20495286	A	C	ncRNA_intronic	CHEK2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	238	chr15	20495286	chr15:20495286	A	C	159	PASS	AN=2;DP=238	GT	0/1
chr15	20495339	20495339	C	T	ncRNA_intronic	CHEK2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	334	chr15	20495339	chr15:20495339	C	T	106	PASS	AN=2;DP=334	GT	0/1
chr15	30808681	30808681	G	A	intergenic	LOC100288203;DNM1P50	dist=26165;dist=52120	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	392	chr15	30808681	chr15:30808681	G	A	136	PASS	AN=2;DP=392	GT	0/1
chr15	43622483	43622483	C	A	exonic	LCMT2	.	nonsynonymous SNV	LCMT2:NM_014793:exon1:c.G205T:p.A69S	7.27E-08	0.268667513	0.731332415	.	0.07788	0.11769	-0.042196577	50.49539986	231.36801	3.28766	0.504	0.076	T	0.506	0.354	P	0.281	0.386	B	0.052	0.229	N	1	0.810	D	1.445	0.365	L	1.9	0.235	T	0.34	0.038	N	0.264	0.321	-1.123	0.022	T	0.047	0.201	T	0.024	0.472	T	2.050	0.307	16.53	0.832	0.141	0.946	0.614	D	c	-0.343	-0.246	1.000	0.747	0.006	0.001	3	4.63	0.570	3.175	0.503	0.049	0.161	1.000	0.715	0.311	0.239	12.395	0.545	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	92	138	chr15	43622483	chr15:43622483	C	A	92	PASS	AN=2;DP=138	GT	0/1
chr15	59981640	59981640	C	A	UTR5	BNIP2	NM_001320674:c.-1G>T;NM_004330:c.-1G>T	.	.	1.69E-05	0.671754446	0.328228624	.	0.59599	0.12477	-0.336073593	30.55555556	3900.56272	12.33278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	189	chr15	59981640	chr15:59981640	C	A	128	PASS	AN=2;DP=189	GT	0/1
chr15	63481976	63481976	G	T	intronic	RAB8B	.	.	.	0.049515248	0.92805035	0.022434402	.	0.09665	0.13588	-0.053113545	49.38664779	6.15812	0.23191	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	chr15	63481976	chr15:63481976	G	T	.	PASS	AN=0;DP=59	GT	0/1
chr15	102516373	102516373	C	T	ncRNA_exonic	WASH3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	619	chr15	102516373	chr15:102516373	C	T	149	PASS	AN=2;DP=619	GT	0/1
chr16	1245077	1245077	C	T	exonic	CACNA1H	.	synonymous SNV	CACNA1H:NM_001005407:exon3:c.C405T:p.I135I,CACNA1H:NM_021098:exon3:c.C405T:p.I135I	0.755916976	0.244083023	1.19E-09	DISEASE: Epilepsy, idiopathic generalized 6 (EIG6) [MIM:611942]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. {ECO:0000269|PubMed:15048902}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epilepsy, childhood absence 6 (ECA6) [MIM:611942]: A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood. {ECO:0000269|PubMed:12891677}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.1215	0.15825	-2.059460781	1.627742392	3476.91536	11.35078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	95	chr16	1245077	chr16:1245077	C	T	65	PASS	AN=2;DP=95	GT	0/1
chr16	1402200	1402200	G	T	intronic	GNPTG	.	.	.	6.00E-08	0.243287932	0.756712008	DISEASE: Mucolipidosis type III complementation group C (MLIIIC) [MIM:252605]: Autosomal recessive disease of lysosomal hydrolase trafficking. Unlike the related diseases, mucolipidosis II and IIIA, the enzyme affected in mucolipidosis IIIC (GlcNAc- phosphotransferase) retains full transferase activity on synthetic substrates but lacks activity on lysosomal hydrolases. Typical clinical findings include stiffness of the hands and shoulders, claw-hand deformity, scoliosis, short stature, coarse facies, and mild mental retardation. Radiographically, severe dysostosis multiplex of the hip is characteristic and frequently disabling. The clinical diagnosis can be confirmed by finding elevated serum lysosomal enzyme levels and/or decreased lysosomal enzyme levels in cultured fibroblasts. {ECO:0000269|PubMed:10712439, ECO:0000269|PubMed:15532026, ECO:0000269|PubMed:24316125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTG have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.11006	0.14352	-0.334253673	30.70299599	52.40877	1.43216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	53	chr16	1402200	chr16:1402200	G	T	113	PASS	AN=2;DP=53	GT	0/1
chr16	2030628	2030628	C	T	intronic	NOXO1	.	.	.	3.17E-11	0.011808231	0.988191769	.	0.0626	0.1393	0.240763792	69.36777542	563.1205	4.81832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	251	chr16	2030628	chr16:2030628	C	T	101	PASS	AN=2;DP=251	GT	0/1
chr16	23702685	23702685	G	T	exonic	ERN2	.	nonsynonymous SNV	ERN2:NM_001308220:exon19:c.C2282A:p.A761E,ERN2:NM_033266:exon20:c.C2438A:p.A813E	1.79E-15	0.517166148	0.482833852	.	0.37292	0.11979	-1.697674421	2.583156405	1512.87602	7.22771	0.991	0.030	T	0.002	0.349	B	0.012	0.360	B	0.001	0.403	N	0.540	0.314	N	1.595	0.408	L	1.58	0.291	T	-0.93	0.249	N	0.264	0.321	-1.057	0.126	T	0.046	0.199	T	0.010	0.263	T	1.702	0.266	14.42	0.941	0.237	0.893	0.494	D	c	-0.441	-0.289	1.000	0.747	0.676	0.548	0	4.83	0.617	1.374	0.337	1.048	0.713	0.601	0.275	0.985	0.512	13.880	0.630	KEN domain;KEN domain|PUG domain	.	.	0.5	81	217	chr16	23702685	chr16:23702685	G	T	81	PASS	AN=2;DP=217	GT	0/1
chr16	29431068	29431068	C	T	intergenic	NPIPB11;SMG1P6	dist=15945;dist=5664	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	685	chr16	29431068	chr16:29431068	C	T	86	PASS	AN=2;DP=685	GT	0/1
chr16	29498327	29498327	G	A	intergenic	LOC388242;SMG1P2	dist=19428;dist=58005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.370	0.064	0.457	0.361	0.023	0.001	0.006	N	n	-0.443	-0.240	0.000	0.012	0.078	0.016	0	-1.06	0.094	0.064	0.142	0.177	0.246	0.185	0.239	0.091	0.185	.	.	.	.	.	0.5	96	284	chr16	29498327	chr16:29498327	G	A	96	PASS	AN=2;DP=284	GT	0/1
chr16	29624821	29624821	C	T	ncRNA_exonic	SMG1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	251	chr16	29624821	chr16:29624821	C	T	124	PASS	AN=2;DP=251	GT	0/1
chr16	31008054	31008054	C	T	exonic	STX1B	.	nonsynonymous SNV	STX1B:NM_052874:exon7:c.G487A:p.E163K	0.944474733	0.05548414	4.11E-05	DISEASE: Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172]: An autosomal dominant neurologic disorder characterized by febrile and/or afebrile seizures manifesting in early childhood. Seizure are variable and include generalized tonic-clonic, atonic, myoclonic, complex partial, and absence types. Most patients have remission of seizures later in childhood with no residual neurologic deficits. Rarely, patients may show mild developmental delay or mild intellectual disabilities. {ECO:0000269|PubMed:25362483}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22761	0.14229	-0.163345027	41.24793583	5.61252	0.20995	0.001	0.784	D	0.613	0.418	P	0.319	0.399	B	0.000	0.629	D	1	0.810	D	2.33	0.670	M	0.28	0.591	T	-3.86	0.726	D	0.923	0.918	-0.219	0.772	T	0.297	0.669	T	0.085	0.745	D	5.918	0.812	27.5	0.999	0.983	0.992	0.920	D	c	0.605	0.609	1.0	0.983	0.789	0.998	0	4.76	0.600	7.867	0.854	0.870	0.379	1.000	0.715	0.995	0.604	16.694	0.851	Syntaxin, N-terminal domain|t-SNARE	.	.	0.5	105	243	chr16	31008054	chr16:31008054	C	T	105	PASS	AN=2;DP=243	GT	0/1
chr16	32007186	32007186	G	T	intergenic	ZNF267;LOC102723753	dist=78557;dist=156247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	164	chr16	32007186	chr16:32007186	G	T	.	PASS	AN=0;DP=164	GT	0/1
chr16	32133768	32133768	G	C	intergenic	ZNF267;LOC102723753	dist=205139;dist=29665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	176	711	chr16	32133768	chr16:32133768	G	C	176	PASS	AN=2;DP=711	GT	0/1
chr16	32264985	32264985	G	T	exonic	TP53TG3D	.	nonsynonymous SNV	TP53TG3D:NM_001243722:exon1:c.G311T:p.R104I	0.641056796	0.331383233	0.027559972	.	.	.	.	.	22.6399	0.75766	0.105	0.298	T	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	1.5	0.312	T	-4.65	0.794	D	0.193	0.236	.	.	.	.	.	.	0.013	0.329	T	-1.470	0.018	0.003	0.418	0.030	0.006	0.026	N	n	-0.706	-0.063	0.681	0.225	0.487	0.133	0	.	.	-0.998	0.038	-1.042	0.020	0.003	0.159	0.004	0.083	.	.	.	.	.	0.5	108	554	chr16	32264985	chr16:32264985	G	T	108	PASS	AN=2;DP=554	GT	0/1
chr16	32329429	32329429	G	T	intergenic	LOC390705;TP53TG3E	dist=28127;dist=355416	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	834	chr16	32329429	chr16:32329429	G	T	132	PASS	AN=2;DP=834	GT	0/1
chr16	32859230	32859230	C	A	intergenic	TP53TG3;SLC6A10P	dist=171780;dist=29567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	656	chr16	32859230	chr16:32859230	C	A	114	PASS	AN=2;DP=656	GT	0/1
chr16	32890992	32890992	G	T	ncRNA_exonic	SLC6A10P	.	.	.	.	.	.	.	0.09544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	144	chr16	32890992	chr16:32890992	G	T	89	PASS	AN=2;DP=144	GT	0/1
chr16	32916782	32916782	G	A	intergenic	SLC6A10P;TP53TG3B	dist=20319;dist=288801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	378	chr16	32916782	chr16:32916782	G	A	97	PASS	AN=2;DP=378	GT	0/1
chr16	33123817	33123817	C	A	intergenic	SLC6A10P;TP53TG3B	dist=227354;dist=81766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	271	chr16	33123817	chr16:33123817	C	A	139	PASS	AN=2;DP=271	GT	0/1
chr16	33366720	33366720	A	G	intergenic	LOC390705;ENPP7P13	dist=68018;dist=205124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	395	chr16	33366720	chr16:33366720	A	G	159	PASS	AN=2;DP=395	GT	0/1
chr16	33503779	33503779	C	A	intergenic	LOC390705;ENPP7P13	dist=205077;dist=68065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	660	chr16	33503779	chr16:33503779	C	A	111	PASS	AN=2;DP=660	GT	0/1
chr16	54966439	54966439	G	T	exonic	IRX5	.	nonsynonymous SNV	IRX5:NM_001252197:exon2:c.G279T:p.M93I,IRX5:NM_005853:exon2:c.G279T:p.M93I	.	.	.	DISEASE: Hamamy syndrome (HMMS) [MIM:611174]: A syndrome characterized by severe hypertelorism, upslanting palpebral fissures, brachycephaly, abnormal ears, sloping shoulders, enamel hypoplasia, and osteopenia with repeated fractures. Additional features include myopia, mild to moderate sensorineural hearing loss, gonadal anomalies and borderline intelligence. {ECO:0000269|PubMed:22581230}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66381	0.13039	.	.	1652.69996	7.51371	0.154	0.309	T	0.063	0.219	B	0.168	0.335	B	0.000	0.843	D	1	0.810	D	0.82	0.209	L	0.34	0.592	T	-2.07	0.558	N	0.51	0.570	-0.820	0.539	T	0.188	0.540	T	0.019	0.410	T	2.204	0.326	17.54	0.992	0.553	0.895	0.497	D	c	0.119	0.267	1.000	0.747	0.598	0.340	0	4.68	0.582	6.624	0.739	0.953	0.551	1.000	0.715	0.994	0.587	16.332	0.828	.	.	.	0.5	126	229	chr16	54966439	chr16:54966439	G	T	126	PASS	AN=2;DP=229	GT	0/1
chr16	57088993	57088993	G	T	exonic	NLRC5	.	nonsynonymous SNV	NLRC5:NM_032206:exon25:c.G3646T:p.G1216C,NLRC5:NM_001330552:exon26:c.G3646T:p.G1216C	6.72E-05	0.999932818	2.78E-09	.	0.07927	0.08967	0.514279338	80.30195801	898.09245	5.83754	0.005	0.632	D	0.999	0.899	D	0.906	0.739	P	.	.	.	1	0.090	N	2.48	0.723	M	-0.61	0.740	T	-3.25	0.722	D	0.417	0.522	-0.996	0.312	T	0.132	0.445	T	0.058	0.674	D	3.605	0.491	23.2	0.994	0.649	0.165	0.192	N	c	-0.326	-0.442	0.659	0.222	0.632	0.406	0	2.87	0.324	1.302	0.328	0.108	0.203	0.012	0.185	0.018	0.130	7.330	0.256	Leucine-rich repeat domain, L domain-like	.	.	0.5	95	105	chr16	57088993	chr16:57088993	G	T	95	PASS	AN=2;DP=105	GT	0/1
chr16	84218459	84218459	C	A	exonic	TAF1C	.	stopgain	TAF1C:NM_001243156:exon2:c.G136T:p.E46X,TAF1C:NM_005679:exon2:c.G136T:p.E46X	3.23E-11	0.472377146	0.527622854	.	0.24194	0.0925	0.593325282	82.46048596	1956.88534	8.14058	.	.	.	.	.	.	.	.	.	0.173	0.031	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.443	0.472	23.0	0.894	0.182	0.010	0.037	N	c	-0.490	-0.957	1.000	0.747	0.731	0.878	0	-7.45	0.012	-2.252	0.013	-2.251	0.004	0.000	0.063	0.003	0.074	2.072	0.034	.	.	.	0.5	108	231	chr16	84218459	chr16:84218459	C	A	108	PASS	AN=2;DP=231	GT	0/1
chr16	86600947	86600947	G	T	exonic	FOXC2	.	nonsynonymous SNV	FOXC2:NM_005251:exon1:c.G6T:p.Q2H	.	.	.	DISEASE: Lymphedema-distichiasis (LYD) [MIM:153400]: A disorder characterized by primary limb lymphedema associated with distichiasis (double rows of eyelashes, with extra eyelashes growing from the Meibomian gland orifices). Swelling of the extremities, due to altered lymphatic flow, usually appears in late childhood or puberty. Most affected individuals have ocular findings including corneal irritation, recurrent conjunctivitis, and photophobia. Drooping of the upper eyelid (ptosis) is a variable feature of the lymphedema-distichiasis syndrome, occurring in about 30% of patients. {ECO:0000269|PubMed:11078474, ECO:0000269|PubMed:11371511, ECO:0000269|PubMed:11499682}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.38597	0.23829	.	.	50.82093	1.40445	0.0	0.912	D	0.999	0.764	D	0.99	0.774	D	0.615	0.057	U	0.994	0.422	D	2.015	0.552	M	-4.1	0.967	D	-3.49	0.680	D	0.725	0.724	0.608	0.920	D	0.914	0.972	D	0.585	0.963	D	5.864	0.804	27.3	0.996	0.740	0.975	0.751	D	c	0.453	0.349	1.000	0.747	0.623	0.393	0	1.4	0.213	6.207	0.719	0.952	0.539	1.000	0.715	1.000	0.888	8.527	0.323	.	.	.	0.5	84	133	chr16	86600947	chr16:86600947	G	T	84	PASS	AN=2;DP=133	GT	0/1
chr16	88499564	88499564	C	A	exonic	ZNF469	.	nonsynonymous SNV	ZNF469:NM_001127464:exon2:c.C5602A:p.P1868T	.	.	.	.	.	.	.	.	3862.54073	12.24999	0.0	0.912	D	0.767	0.418	P	0.344	0.408	B	.	.	.	1	0.090	N	1.7	0.440	L	2.21	0.184	T	-2.63	0.564	D	0.305	0.365	-1.052	0.139	T	0.025	0.107	T	0.411	0.936	D	3.911	0.527	23.5	0.952	0.257	0.044	0.098	N	c	-0.393	-0.436	0.443	0.205	0.646	0.450	0	3.49	0.389	0.033	0.135	0.807	0.329	0.000	0.063	0.045	0.161	2.867	0.052	.	.	.	0.5	107	203	chr16	88499564	chr16:88499564	C	A	107	PASS	AN=2;DP=203	GT	0/1
chr16	89592827	89592827	G	C	exonic	SPG7	.	nonsynonymous SNV	SPG7:NM_003119:exon5:c.G709C:p.A237P,SPG7:NM_199367:exon5:c.G709C:p.A237P	1.38E-18	0.005285187	0.994714813	DISEASE: Note=Defects in SPG7 may cause autosomal recessive osteogenesis imperfecta (OI). Osteogenesis imperfecta defines a group of connective tissue disorders characterized by bone fragility and low bone mass. Clinical features of SPG7-related osteogenesis imperfecta include recurrent fractures, mild bone deformities, delayed tooth eruption, normal hearing and white sclera.; 	0.13976	.	-1.052752328	7.619721632	2153.42654	8.54208	1.0	0.022	T	0.0	0.067	B	0.002	0.112	B	0.057	0.225	N	1.000	0.204	N	-0.995	0.012	N	-0.8	0.739	T	0.97	0.058	N	0.13	0.149	-0.999	0.302	T	0.130	0.441	T	0.020	0.430	T	0.999	0.190	10.66	0.608	0.064	0.750	0.364	D	c	-0.665	-0.455	0.547	0.213	0.707	0.730	0	4.36	0.515	2.129	0.414	0.091	0.195	0.842	0.301	0.431	0.259	7.307	0.255	Peptidase M41, FtsH extracellular	.	.	0.5	93	137	chr16	89592827	chr16:89592827	G	C	93	PASS	AN=2;DP=137	GT	0/1
chr17	8789796	8789796	C	T	exonic	PIK3R5	.	nonsynonymous SNV	PIK3R5:NM_001251852:exon12:c.G874A:p.E292K,PIK3R5:NM_001251853:exon12:c.G874A:p.E292K,PIK3R5:NM_001251855:exon12:c.G874A:p.E292K,PIK3R5:NM_001142633:exon13:c.G2032A:p.E678K,PIK3R5:NM_001251851:exon13:c.G874A:p.E292K,PIK3R5:NM_014308:exon13:c.G2032A:p.E678K	0.817693684	0.182304778	1.54E-06	DISEASE: Ataxia-oculomotor apraxia 3 (AOA3) [MIM:615217]: An autosomal recessive disease characterized by cerebellar ataxia, oculomotor apraxia, areflexia and peripheral neuropathy. {ECO:0000269|PubMed:22065524}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0917	0.10099	-0.461076406	23.66124086	168.04756	2.8298	0.611	0.054	T	0.998	0.715	D	0.951	0.672	D	0.000	0.629	D	1.000	0.524	D	2.72	0.798	M	-1.13	0.777	T	-0.44	0.146	N	0.408	0.503	-0.518	0.680	T	0.389	0.744	T	0.188	0.861	D	4.478	0.600	24.2	0.942	0.238	0.873	0.465	D	c	-0.045	-0.104	0.829	0.246	0.632	0.406	0	3.24	0.361	4.403	0.592	0.852	0.362	1.000	0.715	0.115	0.194	13.085	0.584	.	.	.	0.5	90	175	chr17	8789796	chr17:8789796	C	T	90	PASS	AN=2;DP=175	GT	0/1
chr17	10417160	10417160	C	A	exonic	MYH1	.	nonsynonymous SNV	MYH1:NM_005963:exon8:c.G719T:p.R240M	1.29E-29	0.041852309	0.958147691	.	0.69127	0.30625	-1.080656478	7.248171739	785.49267	5.53734	0.0	0.912	D	0.999	0.764	D	0.986	0.754	D	0.000	0.481	U	1	0.810	D	2.995	0.861	M	-2.47	0.890	D	-4.87	0.812	D	0.951	0.947	0.981	0.969	D	0.885	0.962	D	0.205	0.870	D	6.732	0.919	32	0.965	0.296	0.959	0.663	D	c	1.028	0.958	1.0	0.983	0.534	0.214	0	5.58	0.843	7.875	0.855	0.935	0.490	1.000	0.715	1.000	0.888	19.947	0.972	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	64	137	chr17	10417160	chr17:10417160	C	A	64	PASS	AN=2;DP=137	GT	0/1
chr17	17707151	17707151	G	A	exonic	RAI1	.	nonsynonymous SNV	RAI1:NM_030665:exon4:c.G5647A:p.A1883T	0.999136112	0.000863888	6.14E-11	DISEASE: Smith-Magenis syndrome (SMS) [MIM:182290]: Characterized by congenital mental retardation associated with development and growth delays. Affected persons have characteristic behavioral abnormalities, including self-injurious behaviors and sleep disturbance, and distinct craniofacial and skeletal anomalies. {ECO:0000269|PubMed:11404004, ECO:0000269|PubMed:12652298}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13693	0.11743	-3.683732498	0.253597547	223.68182	3.23449	0.0	0.912	D	0.999	0.764	D	0.995	0.818	D	.	.	.	1.000	0.810	D	4.17	0.977	H	-0.97	0.757	T	-3.46	0.677	D	0.668	0.791	0.488	0.904	D	0.663	0.883	D	0.358	0.925	D	7.132	0.943	34	0.965	0.295	0.994	0.953	D	c	0.983	0.925	1.000	0.747	0.707	0.730	0	5.46	0.799	9.735	0.980	1.048	0.713	1.000	0.715	0.997	0.653	18.908	0.924	Zinc finger, PHD-type	.	.	0.5	83	146	chr17	17707151	chr17:17707151	G	A	83	PASS	AN=2;DP=146	GT	0/1
chr17	18353610	18353621	GCGGCATCGGGG	-	intergenic	KRT16P1;LGALS9C	dist=7402;dist=26478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	259	chr17	18353609	chr17:18353609	TGCGGCATCGGGG	T	99	PASS	AN=2;DP=259	GT	0/1
chr17	20416895	20416895	A	C	intergenic	KRT16P3;CDRT15L2	dist=9084;dist=66142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	102	chr17	20416895	chr17:20416895	A	C	88	PASS	AN=2;DP=102	GT	0/1
chr17	20418848	20418848	G	T	intergenic	KRT16P3;CDRT15L2	dist=11037;dist=64189	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	196	chr17	20418848	chr17:20418848	G	T	104	PASS	AN=2;DP=196	GT	0/1
chr17	25974223	25974223	G	-	intronic	LGALS9	.	.	.	0.00139054	0.964148727	0.034460733	.	0.13572	0.22025	0.797386419	87.53833451	2358.5758	9.00919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	151	chr17	25974222	chr17:25974222	AG	A	104	PASS	AN=2;DP=151	GT	0/1
chr17	28886747	28886747	G	T	intronic	TBC1D29	.	.	.	8.25E-05	0.321646341	0.678271175	.	0.07418	.	0.215080721	67.91696155	10.20934	0.37212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	198	chr17	28886747	chr17:28886747	G	T	.	PASS	AN=0;DP=198	GT	0/1
chr17	33769038	33769038	C	A	exonic	SLFN13	.	nonsynonymous SNV	SLFN13:NM_144682:exon5:c.G1466T:p.R489L	8.75E-15	0.004834494	0.995165506	.	0.05976	0.06727	2.763559657	98.99740505	1954.11134	8.1348	0.635	0.051	T	0.388	0.327	B	0.083	0.277	B	0.287	0.039	N	1	0.090	P	2.24	0.636	M	4.49	0.035	T	-2.15	0.486	N	0.188	0.241	-0.948	0.414	T	0.008	0.030	T	.	.	.	0.520	0.144	7.585	0.425	0.031	0.004	0.019	N	c	-1.448	-1.614	0.119	0.168	0.707	0.730	0	-6.09	0.020	-6.973	0.001	-2.795	0.002	0.000	0.063	0.000	0.016	5.552	0.163	.	.	.	0.5	166	349	chr17	33769038	chr17:33769038	C	A	166	PASS	AN=2;DP=349	GT	0/1
chr17	34070317	34070317	G	T	UTR3	RASL10B	NM_033315:c.*1993G>T	.	.	0.036792615	0.832766797	0.130440588	.	0.19256	0.11192	0.170987912	65.5579146	48.9651	1.36687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	190	chr17	34070317	chr17:34070317	G	T	99	PASS	AN=2;DP=190	GT	0/1
chr17	39412133	39412133	C	A	exonic	KRTAP9-9	.	nonsynonymous SNV	KRTAP9-9:NM_030975:exon1:c.C496A:p.P166T,KRTAP9-9:NM_001318227:exon2:c.C511A:p.P171T	0.007298706	0.536562679	0.456138614	.	.	0.10345	.	.	5752.9952	15.75321	0.037	0.430	D	0.975	0.561	D	0.763	0.547	P	.	.	.	0.999	0.220	N	.	.	.	4.67	0.018	T	-4.87	0.812	D	0.492	0.539	-0.980	0.350	T	0.013	0.050	T	0.004	0.112	T	4.329	0.580	24.0	0.993	0.575	0.117	0.166	N	c	-0.033	-0.185	0.004	0.103	0.447	0.083	0	1.48	0.218	0.044	0.138	0.718	0.303	0.000	0.063	0.957	0.436	4.831	0.127	.	.	.	0.5	121	355	chr17	39412133	chr17:39412133	C	A	121	PASS	AN=2;DP=355	GT	0/1
chr17	40660662	40660662	C	T	intronic	ATP6V0A1	.	.	.	0.997249735	0.002750265	4.23E-11	.	0.44599	0.50341	-0.688817379	15.20405756	53.36179	1.45103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	192	chr17	40660662	chr17:40660662	C	T	74	PASS	AN=2;DP=192	GT	0/1
chr17	43626397	43626397	G	C	intergenic	LRRC37A4P;MAPK8IP1P2	dist=28508;dist=51072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	298	chr17	43626397	chr17:43626397	G	C	118	PASS	AN=2;DP=298	GT	0/1
chr17	45727525	45727525	C	T	UTR5	KPNB1	NM_002265:c.-86C>T	.	.	0.999994328	5.67E-06	7.22E-15	.	0.99948	0.5595	-0.624497208	17.16206653	28.74247	0.91953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	162	chr17	45727525	chr17:45727525	C	T	85	PASS	AN=2;DP=162	GT	0/1
chr17	60217010	60217010	G	T	intergenic	MED13;TBC1D3P2	dist=74367;dist=125057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	122	chr17	60217010	chr17:60217010	G	T	74	PASS	AN=2;DP=122	GT	0/1
chr17	60345044	60345044	A	T	ncRNA_intronic	TBC1D3P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	130	chr17	60345044	chr17:60345044	A	T	.	PASS	AN=0;DP=130	GT	0/1
chr17	62009640	62009640	G	T	UTR5	CD79B	NM_021602:c.-19C>A;NM_000626:c.-19C>A;NM_001329050:c.-19C>A;NM_001039933:c.-19C>A	.	.	0.950002657	0.049842119	0.000155224	DISEASE: Agammaglobulinemia 6, autosomal recessive (AGM6) [MIM:612692]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:17675462}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24113	0.3219	-0.449946534	24.00330267	9.1864	0.3355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	185	chr17	62009640	chr17:62009640	G	T	130	PASS	AN=2;DP=185	GT	0/1
chr17	72736980	72736980	C	T	exonic	RAB37	.	nonsynonymous SNV	RAB37:NM_001006638:exon2:c.C167T:p.S56F,RAB37:NM_001163989:exon2:c.C182T:p.S61F,RAB37:NM_001330471:exon2:c.C86T:p.S29F	8.23E-05	0.76782021	0.23209752	.	0.08186	0.11813	0.040529541	57.15380986	48.09219	1.35018	0.003	0.721	D	0.884	0.473	P	0.816	0.571	P	0.000	0.449	D	0.999	0.810	D	2.03	0.557	M	-1.14	0.779	T	-3.79	0.724	D	0.38	0.440	0.185	0.857	D	0.556	0.838	D	0.226	0.881	D	5.061	0.682	25.2	0.998	0.867	0.990	0.891	D	c	0.476	0.436	1.000	0.747	0.706	0.609	0	5.1	0.688	4.832	0.622	0.921	0.432	1.000	0.715	0.999	0.750	17.296	0.870	P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	71	200	chr17	72736980	chr17:72736980	C	T	71	PASS	AN=2;DP=200	GT	0/1
chr17	75495353	75495353	C	G	UTR3	SEPT9	NM_001293695:c.*613C>G;NM_001113491:c.*613C>G;NM_001113492:c.*613C>G;NM_006640:c.*613C>G;NM_001113493:c.*613C>G;NM_001113494:c.*613C>G;NM_001293696:c.*613C>G;NM_001113496:c.*613C>G;NM_001293697:c.*613C>G;NM_001293698:c.*613C>G;NM_001113495:c.*613C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	184	chr17	75495353	chr17:75495353	C	G	88	PASS	AN=2;DP=184	GT	0/1
chr17	79683805	79683805	G	A	intronic	SLC25A10	.	.	.	0.002439368	0.928274848	0.069285784	.	0.18311	0.12721	-0.448125345	24.19202642	41.5856	1.21268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	182	chr17	79683805	chr17:79683805	G	A	98	PASS	AN=2;DP=182	GT	0/1
chr18	14542791	14542791	C	T	exonic	POTEC	.	nonsynonymous SNV	POTEC:NM_001137671:exon1:c.G355A:p.A119T	0.161704414	0.835123744	0.003171842	.	0.10352	0.06565	.	.	920.22285	5.89584	0.353	0.122	T	0.005	0.119	B	0.002	0.063	B	.	.	.	1	0.090	N	0.895	0.225	L	1.66	0.275	T	-0.93	0.249	N	0.076	0.095	-1.004	0.289	T	0.040	0.174	T	.	.	.	-0.064	0.088	2.011	0.827	0.139	0.005	0.023	N	c	-1.512	-1.612	0.000	0.012	0.487	0.133	0	-0.375	0.118	-1.381	0.026	-1.965	0.005	0.000	0.063	0.001	0.043	.	.	Ankyrin repeat-containing domain	.	.	0.5	130	479	chr18	14542791	chr18:14542791	C	T	130	PASS	AN=2;DP=479	GT	0/1
chr19	1430298	1430298	C	A	exonic	DAZAP1	.	nonsynonymous SNV	DAZAP1:NM_018959:exon10:c.C808A:p.P270T,DAZAP1:NM_170711:exon10:c.C808A:p.P270T	0.999571004	0.000428995	1.35E-09	.	0.16252	0.11134	-0.538132194	20.26421326	275.74527	3.55666	0.262	0.189	T	0.003	0.192	B	0.002	0.154	B	0.000	0.843	D	1.000	0.588	D	0.345	0.112	N	1.26	0.363	T	-0.86	0.234	N	0.425	0.481	-1.059	0.119	T	0.041	0.177	T	0.022	0.447	T	1.801	0.277	14.99	0.831	0.141	0.928	0.562	D	c	-0.425	-0.256	1.000	0.747	0.672	0.522	0	5.0	0.661	5.422	0.660	0.848	0.348	1.000	0.715	0.679	0.305	12.011	0.524	.	.	.	0.5	75	363	chr19	1430298	chr19:1430298	C	A	75	PASS	AN=2;DP=363	GT	0/1
chr19	2038185	2038185	C	T	UTR3	MKNK2	NM_199054:c.*1427G>A	.	.	9.34E-06	0.777281387	0.222709276	.	0.18067	0.14759	-0.576764155	18.7839113	742.98614	5.41125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	113	chr19	2038185	chr19:2038185	C	T	.	PASS	AN=0;DP=113	GT	0/1
chr19	4508855	4508855	G	T	exonic	PLIN4	.	nonsynonymous SNV	PLIN4:NM_001080400:exon4:c.C3585A:p.H1195Q	1.66E-12	0.007710433	0.992289567	.	0.16259	0.102	5.994578529	99.85845718	9818.87991	21.57786	0.01	0.564	D	1.0	0.899	D	0.983	0.742	D	0.000	0.473	D	1.000	0.191	N	3.06	0.872	M	2.22	0.182	T	-6.83	0.930	D	0.705	0.708	-1.075	0.083	T	0.075	0.301	T	0.045	0.617	D	4.476	0.599	24.2	0.990	0.492	0.078	0.136	N	c	-0.392	-0.605	0.001	0.078	0.581	0.326	0	-1.18	0.091	-1.209	0.031	-1.161	0.017	0.004	0.165	0.040	0.157	7.974	0.291	.	.	.	0.5	119	182	chr19	4508855	chr19:4508855	G	T	119	PASS	AN=2;DP=182	GT	0/1
chr19	5787234	5787234	C	T	intronic	DUS3L	.	.	.	2.45E-09	0.447364589	0.552635408	.	0.16355	.	-0.685180376	15.32200991	3219.59367	10.81274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	209	chr19	5787234	chr19:5787234	C	T	105	PASS	AN=2;DP=209	GT	0/1
chr19	11591394	11591394	C	A	intronic	ELAVL3	.	.	.	0.822602584	0.176556392	0.000841025	.	0.39015	0.23372	-0.780646273	12.77423921	9.21155	0.33694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	237	chr19	11591394	chr19:11591394	C	A	65	PASS	AN=2;DP=237	GT	0/1
chr19	16653215	16653215	C	G	UTR5	CHERP	NM_006387:c.-26G>C	.	.	0.999988396	1.16E-05	2.04E-13	.	0.24899	0.1174	-1.087493118	7.106628922	30.28923	0.96588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	83	chr19	16653215	chr19:16653215	C	G	90	PASS	AN=2;DP=83	GT	0/1
chr19	36122319	36122319	G	T	intronic	RBM42	.	.	.	0.759889531	0.239708836	0.000401633	.	0.204	0.11141	-0.293801652	32.93819297	28.6708	0.91789	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	142	chr19	36122319	chr19:36122319	G	T	118	PASS	AN=2;DP=142	GT	0/1
chr19	36487002	36487002	G	T	UTR3	SDHAF1	NM_001042631:c.*478G>T	.	.	0.106593834	0.5920706	0.301335566	.	.	.	.	.	13.08923	0.47642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	108	chr19	36487002	chr19:36487002	G	T	133	PASS	AN=2;DP=108	GT	0/1
chr19	38708053	38708053	C	A	intronic	DPF1	.	.	.	0.98898605	0.011013201	7.50E-07	.	0.28964	0.10376	-0.315847836	31.68789809	13.71775	0.49728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	121	chr19	38708053	chr19:38708053	C	A	67	PASS	AN=2;DP=121	GT	0/1
chr19	41074106	41074106	C	T	exonic	SPTBN4	.	nonsynonymous SNV	SPTBN4:NM_020971:exon31:c.C6874T:p.R2292W	.	.	.	.	0.16131	0.15197	-1.824619408	2.129039868	5101.64368	14.64602	0.0	0.912	D	0.997	0.764	D	0.551	0.575	P	0.000	0.473	U	0.965	0.385	D	0	0.065	N	-1.43	0.807	T	-1.74	0.412	N	0.457	0.509	-0.090	0.803	T	0.452	0.786	T	0.271	0.899	D	7.746	0.955	35	0.999	0.951	0.825	0.414	D	c	0.066	0.080	1.000	0.747	0.598	0.340	0	3.64	0.407	1.957	0.398	0.004	0.136	1.000	0.715	0.117	0.195	13.106	0.585	.	.	.	0.5	87	229	chr19	41074106	chr19:41074106	C	T	87	PASS	AN=2;DP=229	GT	0/1
chr19	41332171	41332171	C	T	intergenic	CYP2T1P;CYP2A6	dist=15166;dist=17272	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	136	chr19	41332171	chr19:41332171	C	T	98	PASS	AN=2;DP=136	GT	0/1
chr19	43883057	43883057	C	T	intergenic	CD177;TEX101	dist=15733;dist=9706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	237	chr19	43883057	chr19:43883057	C	T	127	PASS	AN=2;DP=237	GT	0/1
chr19	46299138	46299138	-	CTCCTCGCCCTCCTCCTC	exonic	RSPH6A	.	nonframeshift insertion	RSPH6A:NM_030785:exon6:c.2142_2143insGAGGAGGAGGGCGAGGAG:p.E714_T715insEEEGEE	2.55E-08	0.471013996	0.528985978	.	0.0719	.	-1.056370776	7.578438311	752.26224	5.4399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	82	chr19	46299138	chr19:46299138	T	TCTCCTCGCCCTCCTCCTC	117	PASS	AN=2;DP=82	GT	0/1
chr19	48306724	48306724	G	T	intronic	TPRX1	.	.	.	0.000613268	0.485833234	0.513553498	.	0.23746	.	-0.115612493	45.12856806	2120.83171	8.47905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	252	chr19	48306724	chr19:48306724	G	T	80	PASS	AN=2;DP=252	GT	0/1
chr19	49468728	49468728	A	T	UTR5	FTL	NM_000146:c.-37A>T	.	.	0.000458653	0.427809813	0.571731534	DISEASE: Hereditary hyperferritinemia-cataract syndrome (HHCS) [MIM:600886]: An autosomal dominant disease characterized by elevated level of ferritin in serum and tissues, and early-onset bilateral cataract. {ECO:0000269|PubMed:19176363}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurodegeneration with brain iron accumulation 3 (NBIA3) [MIM:606159]: A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. It is characterized by a variety of neurological signs including parkinsonism, ataxia, corticospinal signs, mild non-progressive cognitive deficit and episodic psychosis. It is linked with decreased serum ferritin levels. {ECO:0000269|PubMed:16116125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: L-ferritin deficiency (LFTD) [MIM:615604]: A condition characterized by low levels of ferritin in serum and tissues in the absence of other hematological symptoms. Seizures and mild neuropsychologic impairment may manifest in individuals with complete ferritin deficiency. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08288	0.64843	-0.163345027	41.24793583	10.88019	0.39394	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	178	481	chr19	49468728	chr19:49468728	A	T	178	PASS	AN=2;DP=481	GT	0/1
chr19	49897776	49897776	G	C	exonic	CCDC155	.	synonymous SNV	CCDC155:NM_144688:exon3:c.G87C:p.P29P	7.22E-07	0.896888585	0.103110692	.	.	0.07875	-0.176292081	40.56381222	104.6039	2.21065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	chr19	49897776	chr19:49897776	G	C	.	PASS	AN=0;DP=58	GT	0/1
chr19	50364584	50364584	G	A	exonic	PNKP	.	nonsynonymous SNV	PNKP:NM_007254:exon17:c.C1487T:p.S496F	2.88E-07	0.750458365	0.249541347	DISEASE: Microcephaly, seizures, and developmental delay (MCSZ) [MIM:613402]: A disease characterized by infantile-onset seizures, microcephaly, severe intellectual disability and delayed motor milestones with absent speech or only achieving a few words. Most patients also have behavioral problems with hyperactivity. Microcephaly is progressive and without neuronal migration or structural abnormalities, consistent with primary microcephaly. {ECO:0000269|PubMed:20118933}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ataxia-oculomotor apraxia 4 (AOA4) [MIM:616267]: An autosomal recessive disease characterized by cerebellar ataxia, oculomotor apraxia, areflexia and peripheral neuropathy. {ECO:0000269|PubMed:25728773}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3405	0.1816	-0.529034136	20.85987261	306.43839	3.7256	0.02	0.496	D	0.04	0.227	B	0.04	0.342	B	0.360	0.137	U	0.987	0.245	N	2.275	0.649	M	0.97	0.425	T	-3.59	0.692	D	0.266	0.323	-0.998	0.306	T	0.061	0.255	T	0.039	0.589	D	2.956	0.416	22.1	0.988	0.467	0.441	0.270	N	c	-0.737	-0.691	1.000	0.747	0.742	0.980	0	2.46	0.289	2.298	0.430	-0.363	0.068	0.267	0.248	0.005	0.090	5.644	0.167	P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	123	272	chr19	50364584	chr19:50364584	G	A	123	PASS	AN=2;DP=272	GT	0/1
chr19	53014793	53014793	G	T	exonic	ZNF578	.	nonsynonymous SNV	ZNF578:NM_001099694:exon6:c.G1159T:p.V387L	8.81E-14	0.002639121	0.997360879	.	.	.	1.047190339	91.34229771	336.42783	3.89648	.	.	.	0.002	0.090	B	0.001	0.040	B	.	.	.	1	0.090	N	0.01	0.080	N	2.49	0.145	T	.	.	.	0.078	0.097	-1.016	0.249	T	0.036	0.157	T	0.001	0.004	T	-0.021	0.092	2.389	0.760	0.109	0.014	0.047	N	c	-1.326	-1.434	0.000	0.029	0.487	0.133	0	-2.57	0.059	-3.182	0.006	-2.389	0.003	0.000	0.063	0.000	0.016	3.497	0.072	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	148	237	chr19	53014793	chr19:53014793	G	T	148	PASS	AN=2;DP=237	GT	0/1
chr19	54745682	54745682	C	T	exonic	LILRA6;LILRB3	.	nonsynonymous SNV	LILRB3:NM_001081450:exon4:c.G428A:p.R143Q,LILRB3:NM_001320960:exon4:c.G428A:p.R143Q,LILRB3:NM_006864:exon4:c.G428A:p.R143Q,LILRA6:NM_024318:exon4:c.G419A:p.R140Q	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	chr19	54745682	chr19:54745682	C	T	.	PASS	AN=0;DP=93	GT	0/1
chr19	54778505	54778505	C	G	UTR3	LILRB2	NM_001278403:c.*32G>C;NM_001278404:c.*32G>C;NM_005874:c.*32G>C;NM_001080978:c.*32G>C;NM_001278405:c.*220G>C	.	.	7.83E-06	0.979376847	0.020615324	.	0.31832	.	2.831581484	99.08586931	3895.89182	12.31761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	108	chr19	54778505	chr19:54778505	C	G	140	PASS	AN=2;DP=108	GT	0/1
chr19	54782405	54782405	C	G	exonic	LILRB2	.	nonsynonymous SNV	LILRB2:NM_001278404:exon6:c.G619C:p.G207R,LILRB2:NM_001278405:exon6:c.G967C:p.G323R,LILRB2:NM_001278406:exon6:c.G967C:p.G323R,LILRB2:NM_001080978:exon7:c.G967C:p.G323R,LILRB2:NM_001278403:exon7:c.G967C:p.G323R,LILRB2:NM_005874:exon7:c.G967C:p.G323R	7.83E-06	0.979376847	0.020615324	.	0.31832	.	2.831581484	99.08586931	3895.89182	12.31761	0.254	0.203	T	0.709	0.401	P	0.439	0.439	B	0.114	0.027	N	1	0.090	N	0.08	0.083	N	5.79	0.007	T	-1.54	0.373	N	0.152	0.276	-0.988	0.331	T	0.003	0.009	T	0.003	0.057	T	-0.286	0.069	0.714	0.677	0.082	0.002	0.010	N	c	-1.095	-1.318	0.999	0.381	0.447	0.083	0	-3.77	0.040	-1.813	0.018	-1.204	0.016	0.000	0.063	0.000	0.016	0.771	0.009	Immunoglobulin-like domain;Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	109	chr19	54782405	chr19:54782405	C	G	.	PASS	AN=0;DP=109	GT	0/1
chr19	55106288	55106288	A	C	exonic	LILRA1	.	nonsynonymous SNV	LILRA1:NM_001278319:exon3:c.A229C:p.I77L,LILRA1:NM_001278318:exon4:c.A229C:p.I77L,LILRA1:NM_006863:exon4:c.A229C:p.I77L	1.54E-16	0.000861763	0.999138237	.	0.03809	.	2.539299607	98.72021703	2966.18722	10.32448	0.384	0.165	T	0.0	0.026	B	0.0	0.063	B	0.222	0.035	N	1	0.090	N	-2.02	0.002	N	5.83	0.007	T	0.68	0.022	N	0.035	0.202	-0.917	0.459	T	0.001	0.003	T	.	.	.	-1.537	0.016	0.002	0.802	0.126	0.000	0.002	N	c	-1.960	-1.968	1.000	0.517	0.610	0.352	0	-1.94	0.071	-3.526	0.005	-1.428	0.011	0.000	0.063	0.000	0.016	4.396	0.107	Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	109	97	chr19	55106288	chr19:55106288	A	C	109	PASS	AN=2;DP=97	GT	0/1
chr19	55209143	55209143	C	A	intergenic	LILRB4;LILRP2	dist=27333;dist=10557	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	224	chr19	55209143	chr19:55209143	C	A	91	PASS	AN=2;DP=224	GT	0/1
chr19	55795450	55795450	G	A	upstream	BRSK1	dist=84	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.964	0.297	15.99	0.967	0.301	0.647	0.322	D	n	1.646	1.800	1.000	0.747	0.199	0.033	0	3.47	0.387	0.665	0.246	0.758	0.310	0.998	0.411	1.000	0.888	9.250	0.365	.	.	.	0.5	84	319	chr19	55795450	chr19:55795450	G	A	84	PASS	AN=2;DP=319	GT	0/1
chr20	2124496	2124496	G	T	UTR3	STK35	NM_080836:c.*104G>T	.	.	0.918199526	0.081264275	0.000536199	.	0.19968	0.11306	.	.	1408.18303	7.0104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	213	chr20	2124496	chr20:2124496	G	T	126	PASS	AN=2;DP=213	GT	0/1
chr20	5296578	5296578	C	T	intronic	PROKR2	.	.	.	0.000669053	0.503920664	0.495410283	.	0.16785	0.13372	-0.222203495	37.54423213	340.77102	3.91723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	98	chr20	5296578	chr20:5296578	C	T	90	PASS	AN=2;DP=98	GT	0/1
chr20	29449597	29449597	G	A	intergenic	NONE;LINC01597	dist=NONE;dist=63987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	496	chr20	29449597	chr20:29449597	G	A	147	PASS	AN=2;DP=496	GT	0/1
chr20	29516584	29516584	G	T	ncRNA_exonic	LINC01597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	270	chr20	29516584	chr20:29516584	G	T	120	PASS	AN=2;DP=270	GT	0/1
chr20	29612200	29612200	C	T	ncRNA_intronic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	294	chr20	29612200	chr20:29612200	C	T	126	PASS	AN=2;DP=294	GT	0/1
chr20	29614343	29614343	G	A	ncRNA_intronic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	222	chr20	29614343	chr20:29614343	G	A	109	PASS	AN=2;DP=222	GT	0/1
chr20	29628263	29628263	A	G	ncRNA_exonic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	0.307	0.141	T	0.0	0.067	B	0.018	0.206	B	0.000	0.843	D	0.634	0.328	D	.	.	.	.	.	.	-0.57	0.172	N	0.489	0.536	-1.056	0.127	T	0.055	0.231	T	0.001	0.003	T	1.583	0.252	13.76	0.942	0.239	0.631	0.317	D	c	-0.318	-0.243	1.000	0.489	0.752	0.988	0	2.08	0.260	4.712	0.613	0.666	0.294	1.000	0.715	0.993	0.574	3.866	0.085	Actin cross-linking	.	.	0.5	153	842	chr20	29628263	chr20:29628263	A	G	153	PASS	AN=2;DP=842	GT	0/1
chr20	29628335	29628335	A	T	ncRNA_intronic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	196	316	chr20	29628335	chr20:29628335	A	T	196	PASS	AN=2;DP=316	GT	0/1
chr20	29632570	29632571	AG	-	ncRNA_intronic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	281	chr20	29632569	chr20:29632569	CAG	C	94	PASS	AN=2;DP=281	GT	0/1
chr20	37590929	37590929	T	C	upstream	DHX35	dist=52	.	.	9.69E-11	0.973981761	0.026018239	.	0.27324	0.09942	-0.328796968	30.86223166	2233.3121	8.70874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	128	chr20	37590929	chr20:37590929	T	C	107	PASS	AN=2;DP=128	GT	0/1
chr20	42165027	42165027	G	T	intronic	L3MBTL1	.	.	.	2.08E-07	0.993446403	0.006553389	.	0.41701	0.10262	0.025760883	55.78556263	239.20304	3.34244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	141	chr20	42165027	chr20:42165027	G	T	86	PASS	AN=2;DP=141	GT	0/1
chr20	50241868	50241868	C	G	exonic	ATP9A	.	nonsynonymous SNV	ATP9A:NM_006045:exon18:c.G1879C:p.D627H	0.999980637	1.94E-05	1.19E-15	.	0.13853	0.11774	-1.638744339	2.801368247	81.80933	1.91713	0.023	0.481	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	3.075	0.874	M	-1.53	0.816	D	-4.64	0.806	D	0.844	0.861	0.606	0.920	D	0.716	0.902	D	0.273	0.900	D	6.805	0.925	32	0.996	0.715	0.943	0.604	D	c	0.817	0.746	1.000	0.747	0.706	0.609	0	4.7	0.586	7.494	0.802	0.920	0.431	1.000	0.715	0.988	0.529	17.651	0.880	HAD-like domain|P-type ATPase, cytoplasmic domain N	.	.	0.5	87	147	chr20	50241868	chr20:50241868	C	G	87	PASS	AN=2;DP=147	GT	0/1
chr21	10906989	10906989	C	T	exonic	TPTE	.	synonymous SNV	TPTE:NM_001290224:exon19:c.G1158A:p.R386R,TPTE:NM_199260:exon22:c.G1458A:p.R486R,TPTE:NM_199259:exon23:c.G1518A:p.R506R,TPTE:NM_199261:exon24:c.G1572A:p.R524R	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	191	chr21	10906989	chr21:10906989	C	T	.	PASS	AN=0;DP=191	GT	0/1
chr21	11021097	11021097	G	T	intronic	BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	616	chr21	11021097	chr21:11021097	G	T	123	PASS	AN=2;DP=616	GT	0/1
chr21	11038998	11038998	G	A	UTR3	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:c.*668C>T;NM_182481:c.*668C>T;NM_181704:c.*883C>T;NM_182484:c.*883C>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	408	chr21	11038998	chr21:11038998	G	A	129	PASS	AN=2;DP=408	GT	0/1
chr21	11049461	11049461	G	T	UTR3	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:c.*110C>A;NM_182481:c.*110C>A;NM_181704:c.*325C>A;NM_182484:c.*325C>A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	499	chr21	11049461	chr21:11049461	G	T	117	PASS	AN=2;DP=499	GT	0/1
chr21	11049596	11049596	C	T	exonic	BAGE2;BAGE3	.	nonsynonymous SNV	BAGE3:NM_182481:exon4:c.G305A:p.C102Y,BAGE2:NM_182482:exon4:c.G305A:p.C102Y	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	226	chr21	11049596	chr21:11049596	C	T	97	PASS	AN=2;DP=226	GT	0/1
chr21	11058353	11058353	T	C	intronic	BAGE;BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	295	chr21	11058353	chr21:11058353	T	C	115	PASS	AN=2;DP=295	GT	0/1
chr21	11058377	11058377	C	T	intronic	BAGE;BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	184	chr21	11058377	chr21:11058377	C	T	86	PASS	AN=2;DP=184	GT	0/1
chr21	14485395	14485395	C	T	ncRNA_intronic	ANKRD30BP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	163	441	chr21	14485395	chr21:14485395	C	T	163	PASS	AN=2;DP=441	GT	0/1
chr21	14721685	14721685	C	G	intergenic	ANKRD30BP2;MIR3156-3	dist=231114;dist=57020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	106	chr21	14721685	chr21:14721685	C	G	.	PASS	AN=0;DP=106	GT	0/1
chr21	32508223	32508223	C	A	intronic	TIAM1	.	.	.	0.999932006	6.80E-05	1.04E-15	.	0.48136	0.33272	-0.913225292	9.843123378	5001.55165	14.43752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	108	chr21	32508223	chr21:32508223	C	A	80	PASS	AN=2;DP=108	GT	0/1
chr21	35467710	35467720	TGGAGCTGCAA	-	exonic	SLC5A3	.	frameshift deletion	SLC5A3:NM_006933:exon2:c.213_223del:p.G72Wfs*35	0.84946475	0.149995365	0.000539885	.	0.47678	0.38085	-0.666770504	15.86459071	50.54376	1.39893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	137	chr21	35467709	chr21:35467709	CTGGAGCTGCAA	C	88	PASS	AN=2;DP=137	GT	0/1
chr22	16267032	16267032	C	A	exonic	POTEH	.	nonsynonymous SNV	POTEH:NM_001136213:exon9:c.G1417T:p.G473C	.	.	.	.	0.04666	0.08864	.	.	531.82086	4.70466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	551	chr22	16267032	chr22:16267032	C	A	127	PASS	AN=2;DP=551	GT	0/1
chr22	20295384	20295384	C	-	intergenic	RTN4R;DGCR6L	dist=39568;dist=6377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	125	chr22	20295383	chr22:20295383	GC	G	88	PASS	AN=2;DP=125	GT	0/1
chr22	21057318	21057318	G	A	ncRNA_exonic	TMEM191A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	129	chr22	21057318	chr22:21057318	G	A	92	PASS	AN=2;DP=129	GT	0/1
chr22	21354970	21354970	C	G	exonic	THAP7	.	nonsynonymous SNV	THAP7:NM_030573:exon3:c.G343C:p.A115P,THAP7:NM_001008695:exon4:c.G343C:p.A115P	0.029327855	0.923633046	0.047039099	.	0.37131	0.10994	.	.	76.37465	1.83233	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.888	0.087	N	1	0.090	P	-0.345	0.033	N	-3.75	0.955	D	0.94	0.015	N	0.024	0.007	-0.977	0.357	T	0.000	0.000	T	.	.	.	-0.669	0.046	0.085	0.483	0.040	0.009	0.036	N	c	-1.868	-1.808	1.000	0.747	0.628	0.401	0	0.539	0.163	0.097	0.149	-0.760	0.034	0.004	0.165	0.000	0.016	3.205	0.062	.	.	.	0.5	160	92	chr22	21354970	chr22:21354970	C	G	160	PASS	AN=2;DP=92	GT	1/0
chr22	21537822	21537822	C	A	ncRNA_intronic	FAM230B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	247	chr22	21537822	chr22:21537822	C	A	102	PASS	AN=2;DP=247	GT	0/1
chr22	25715733	25715733	G	C	ncRNA_splicing	IGLL3P	NR_029395:exon3:c.216-1G>C	.	.	.	.	.	.	0.05956	0.07001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	chr22	25715733	chr22:25715733	G	C	.	PASS	AN=0;DP=62	GT	0/1
chr22	25771874	25771874	C	A	UTR5	LRP5L	NM_001135772:c.-15815G>T	.	.	3.87E-11	0.00690637	0.99309363	.	0.09203	.	0.756930627	86.79523473	937.76875	5.93572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	298	chr22	25771874	chr22:25771874	C	A	75	PASS	AN=2;DP=298	GT	0/1
chr22	51193209	51193209	T	G	intergenic	ACR;RPL23AP82	dist=9482;dist=2305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	135	chr22	51193209	chr22:51193209	T	G	117	PASS	AN=2;DP=135	GT	0/1
chrX	37028770	37028770	C	A	exonic	FAM47C	.	nonsynonymous SNV	FAM47C:NM_001013736:exon1:c.C2287A:p.R763S	0.057797311	0.86697678	0.075225909	.	0.03714	.	1.76190403	96.75041283	797.36508	5.56605	0.602	0.056	T	0.048	0.207	B	0.011	0.145	B	.	.	.	1	0.090	N	1.32	0.331	L	2.06	0.205	T	-1.64	0.393	N	0.058	0.041	-0.957	0.398	T	0.029	0.123	T	0.001	0.005	T	-1.075	0.029	0.011	0.164	0.004	0.004	0.020	N	.	.	.	0.001	0.077	.	.	.	-1.85	0.073	0.201	0.169	-3.068	0.001	0.000	0.063	0.000	0.016	6.232	0.198	.	.	.	0.5	.	104	chrX	37028770	chrX:37028770	C	A	.	PASS	AN=0;DP=104	GT	0/1
chrX	38420774	38420774	C	A	UTR5	TSPAN7	NM_004615:c.-26C>A	.	.	0.869950131	0.128287984	0.001761884	.	0.27156	0.17096	-0.075159878	47.78839349	0.88041	0.01802	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	120	chrX	38420774	chrX:38420774	C	A	72	PASS	AN=2;DP=120	GT	0/1
chrX	44494322	44494322	C	T	intergenic	FUNDC1;DUSP21	dist=92101;dist=208927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	140	chrX	44494322	chrX:44494322	C	T	82	PASS	AN=2;DP=140	GT	0/1
chrX	110988039	110988039	C	T	exonic	ALG13	.	nonsynonymous SNV	ALG13:NM_001099922:exon24:c.C2839T:p.L947F,ALG13:NM_001257231:exon24:c.C2605T:p.L869F	0.99758296	0.002417037	3.73E-09	DISEASE: Congenital disorder of glycosylation 1S (CDG1S) [MIM:300884]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N- glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:22492991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	-0.999300439	8.368719038	48.1604	1.35199	0.125	0.273	T	0.019	0.167	B	0.022	0.184	B	0.103	0.026	U	1	0.200	N	0	0.065	N	0.4	0.573	T	0.12	0.056	N	0.07	0.089	-1.032	0.197	T	0.097	0.364	T	0.012	0.306	T	-0.456	0.058	0.282	0.991	0.532	0.084	0.141	N	.	.	.	0.003	0.101	.	.	.	1.69	0.232	0.421	0.208	0.874	0.381	0.668	0.281	0.162	0.208	3.250	0.064	.	.	.	0.5	120	288	chrX	110988039	chrX:110988039	C	T	120	PASS	AN=2;DP=288	GT	0/1
chrX	135960119	135960119	C	T	exonic	RBMX	.	nonsynonymous SNV	RBMX:NM_002139:exon4:c.G343A:p.G115R	0.948299697	0.051665932	3.44E-05	DISEASE: Mental retardation, X-linked, syndromic, 11 (MRXS11) [MIM:300238]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS11 patients manifest moderate intellectual disability and craniofacial dysmorphism. {ECO:0000269|PubMed:25256757}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26116	.	0.325313577	73.11276244	16.97983	0.59829	0.089	0.342	T	0.991	0.899	D	0.86	0.832	P	0.000	0.559	U	0.000	0.810	P	2.015	0.552	M	-1.02	0.763	T	-3.62	0.703	D	0.791	0.782	0.130	0.847	D	0.585	0.851	D	.	.	.	5.659	0.771	26.7	0.999	0.995	0.968	0.710	D	.	.	.	1.000	0.747	.	.	.	5.65	0.868	5.492	0.664	0.931	0.441	1.000	0.715	1.000	0.888	16.982	0.861	Nucleotide-binding alpha-beta plait domain	.	.	0.5	118	99	chrX	135960119	chrX:135960119	C	T	118	PASS	AN=2;DP=99	GT	0/1
